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ABSTRACT 
 
Brucella spp. are host specific facultative intracellular pathogens. Brucella abortus is 
responsible for causing abortions in cattle and is also able to cause disease in humans. 
Brucella internalization and intracellular trafficking varies depending on whether the 
bacterium was opsonized or non-opsonized with serum immunoglobulin. Interferon-γ has 
been shown to be critical for the control of B. abortus infection in vivo and in vitro. A family 
of host Immunity-Related p47 guanosine triphosphate-binding proteins (GTPase) induced by 
IFN-γ has been identified that are important for host defense against many intracellular 
pathogens such as M. tuberculosis, T. gondii, and L. monocytogenes. In these studies it was 
found that LRG-47 is required for Brucella survival and replication. Autophagy is a process 
in the cell whereby damaged proteins and organelles are broken down so their contents can 
be reused. In the following studies, an autophagosome-like extracellular organelle has been 
identified that is released by RAW264.7 murine macrophages in normal growth conditions 
and in conditions to induce autophagy. We have observed B. abortus using the natural 
intercellular trafficking pathway of the autophagosome-like extracellular organelle to infect a 
new host cell while evading the host immune system. 
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CHAPTER 1. GENERAL INTRODUCTION 
 
Introduction 
 
Brucella spp. are host specific intracellular pathogens that are able to cause severe 
disease in both mammals and humans.  Brucella abortus is the causative agent of brucellosis 
in cattle which results in abortions or the birth of weak calves. In humans, chronic Brucella 
infection can lead to reproductive defects as well as undulant fever. The mechanism of entry 
and intracellular trafficking varies based on the opsonization status of the Brucella.  
Immunoglobulin-opsonized Brucella enter a macrophage via Fc receptors, whereas non-
opsonized Brucella enter by attachment to lipid rafts on the macrophage surface.  
Phagocytosed bacteria traffic through a modified early and late endosome at which point 
opsonized bacteria stay and replicate.  Non-opsonized Brucella replicate in a compartment 
formed by the endoplasmic reticulum. The host interferon induced p47 GTPase LRG-47 is 
important in host cell defense against a number of pathogens including M. tuberculosis, T. 
gondii, and C. trachomatis. The following studies have demonstrated a requirement for LRG-
47 for Brucella survival and replication. Further, the differences between opsonized and non-
opsonized B. abortus intracellular trafficking as well as the activation state of the 
macrophage contribute to the complex requirement for LRG-47. Though the intracellular 
trafficking pathway for B. abortus has been well described, the mechanism this bacterium 
uses to persist within the host remains unclear. These studies have identified an extracellular 
organelle which can be exploited by B. abortus to traffic from one host cell to the next while 
evading the host immune system.  This knowledge will contribute to the bacterial 
pathogenesis field by possibly providing a mechanism for the trafficking of many 
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intracellular pathogens associated with the autophagy pathway that has, to this point, been 
unable to be explained. 
Dissertation Organization 
 
This thesis is organized into 5 chapters; a general review of the literature pertaining to 
my studies, three chapters to be submitted for publication, and a final concluding chapter 
including suggestions for future research. The first chapter covers bacterial characteristics, 
host protein and process information as well as a justification for the studies. Chapter 2 
describes a host protein, LRG-47, required for Brucella survival and replication inside the 
host cell. A novel autophagosome-like extracellular organelle is identified and examined in 
detail in Chapter 3. In Chapter 4 the mechanism for intercellular transport of Brucella within 
the host via the extracellular organelles identified in Chapter 3 is described. The thesis 
concludes with a chapter providing a general conclusion and recommendations for future 
experiments.   
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LITERATURE REVIEW 
 
Brucella 
 
Brucella overview 
Brucella is a gram negative, non-spore forming, coccobacillus which lives in a 
microaerophilic environment inside its host. It is a partially acidfast bacterium that does not 
contain a native plasmid or express a capsule (1). This small bacterium, approximately 0.6-
1.5 μm in length and 0.5-0.7 μm in diameter, is part of the α2-Proteobacteriacea family of 
bacteria (1). The Brucella species contains many subtypes which include Brucella abortus 
(2), Brucella melitensis (2), Brucella suis, Brucella ovis (3), Brucella canis (4), Brucella 
neotomae (5), Brucella ceti (6, 7), Brucella pinnipedialis (6, 7), and the latest addition, 
Brucella microti (8).  Each of these species is host specific with B. abortus infecting cattle, B. 
canis infecting dogs, B. suis infecting swine (9). All of these species are known to infect 
humans with B. melitensis being the most virulent (8).  Brucella species are extremely 
virulent pathogens. It takes as few as 103 B. abortus organisms to cause disease in a human 
which is why this pathogen has been listed as a category B biowarfare agent by the United 
State Centers for Disease Control and Prevention (CDC) (9). 
Brucella in humans 
Humans are commonly exposed to the bacterium through contact with infected animals, 
inhalation of infected fecal material, or consumption of unpasteurized dairy products and 
undercooked meat products (1). B. abortus transmission  also occurs through mucosal 
membranes and skin abrasions, through the handling of aborted animal tissues, or by human 
to human transmission and accidental laboratory exposures (1). Symptoms are generally 
consistent with those of influenza such as fever, chills, headache, sweats, fatigue, malaise, 
arthralgia, and weight loss (1), which commonly begin anywhere from 2 weeks to 3 months 
after the initial infection (10). Brucellosis is also referred to as “undulant fever” due to the 
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cyclic nature of the fever experienced by chronically infected individuals. Other symptoms 
reported with disease are involuntary limb movement, burning feet, low back ache, and 
ischemic heart attacks (1).  The symptoms of human brucellosis also involve non-specific 
symptomology such as those of gastrointestinal, respiratory, dermal, or neurological 
detriments (11), and are commonly misdiagnosed as diseases such as enteric fever, malaria, 
autoimmune disease, tuberculosis, rheumatic fever, thrombophlebitis, fungal infection, 
tumours, or cholecystitis (1). Clinical manifestations of human brucellosis often include 
those common to many systemic bacterial infections such as liver, spleen, and lymph node 
enlargement (1, 10). Patients often suffer from spondylitis (10), or joint inflammation, which 
occurs in up to 40% of cases (1). Infective endocarditis also be caused by B. abortus 
infection in humans, though this is rare, but deadly (10). Reproductive complications are 
frequently reported in men and women (1). The treatment for brucellosis, as recommended 
by the CDC and the World Health Organization, is the combined daily dose of 600 mg of 
rifampin and 2.0 g doxycycline for 6 weeks (12, 13).  
Brucella in cattle 
Brucella abortus is the primary cause of brucellosis or Bang’s disease in cattle, bison, 
and elk all over the world (8). B. abortus was found to cause varying levels of disease from 
acute to chronic placentitis depending on the route of infection, amount of innoculum, 
virulence of the infecting strain, age and immunological status of the host, reproductive 
status of the host, and natural resistance of the host (8). Brucellosis is contracted by a number 
of different routes including exposure to infected uterine secretions, aborted fetuses, 
consumption of contaminated milk, venereal transmission, inhalation of infected fecal 
material, or infection through the skin, conjungtiva, or gastrointestinal tract (8). The most 
detrimental to the cattle industry is the asymptomatic carrier, who is able to give birth to an 
infected calf who will shed the bacterium throughout its lifetime (8). The end, and most 
concerning, result of brucellosis in cattle is abortion (14). Within two weeks of infection, 
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bacteria  are isolated from the spleen of the animal, and two weeks later are found within 
uterine tissue (14). Initial infection of the placental tissue of the pregnant female happens in 
the erythro-phagocytic trophoblasts (15). B. abortus has a natural tropism for uterine tissue in 
the last trimester of pregnancy (8). This tropism is thought to be due to the hormones 
produced in the uterus during this stage of pregnancy (8), as well as the erythritol present in 
the placental tissue of the cow (15). B. abortus is able to use erythritol as a sole carbon and 
energy source (15).  Interestingly, erythritol was not found in the placentas of humans, mice, 
rabbits, rats, or guinea-pigs, all animals which are infrequently found to have abortive issues 
caused by B. abortus infection (15).  B. abortus infection in cattle causes the calves to be 
weak and sometimes infertile (8). It also causes the adult animal to be leaner with lower milk 
production (8).  
Brucella vaccination 
The most common way to control brucellosis in cattle herds is by preventing it through 
vaccination of calves and adult cows. In the United States there are two attenuated live 
vaccines that are approved for the use in cattle, RB51 and strain 19 (S19) (16). Both RB51 
and S19 are attenuated derivatives of the virulent B. abortus 2308 (16). Much like the 
virulent strain of B. abortus, S19 has a smooth lipopolysaccharide determined by the length 
of the polysaccharide O-side chain  on the cell surface (16). It is thought that the smooth cell 
surface contributes to the bacteria’s virulence, making it better able to enter the host cell (8). 
The S19 vaccine induces an antibody response to long O-side chain (16). This strong 
antibody response is the reason for this vaccine’s effectiveness but also causes a problem as 
the antibodies produced will create a false positive in a serological test for Brucella infection 
(17). RB51 was created by repeated passage of B. abortus 2308 in media containing 
rifampicin (16). The resulting mutant lacks the O-side chain modification resulting in 
attenuation of RB51 in animals and cell culture pathogenesis assays (18). Strain 19 vaccine 
has strong evidence showing that it causes abortions in pregnant cows (16). B. abortus S19 
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and RB51 cause infection in humans and do not afford protective immunity. Currently, no 
human vaccine exists against any species of Brucella. Reducing exposure for humans relies 
solely on the limiting the numbers of infected animals that can serve as a reservoir of the 
zoonosis (17).   
Intracellular lifestyle of non-opsonized Brucella 
Brucella is a facultative intracellular pathogen of resident tissue monocytes and 
macrophages. Internalization of Brucella by these cells occurs either by the bacteria 
interacting directly with the surface of the macrophage or indirectly through the attachment 
of serum opsonins to the bacterial surface. Non-opsonized Brucella are bound by the long O-
chain of their LPS to lipid rafts found occasionally on the surface of the macrophage (19). It 
has also been suggested that class A scavenger receptors in the lipid rafts bind the bacterial 
LPS facilitating uptake into the host cell (20). Lipid raft microdomains are comprised of 
cholesterol, GM1 gangliosides, and glycosylphosphagtidylinositol-anchored proteins (19). 
One hour post infection, the Brucella-containing compartment interacts with the endoplasmic 
reticulum subdomains of the early secretory pathway called ER exit sites (20) (Figure 1.1). 
This interaction of the Brucella-containing vacuole with the ER induces loss of LAMP1 from 
the surface of the vacuole (20). It is at this point that the pH of the Brucella-containing 
compartment increases to become more permissive to Brucella replication as a pH above 5.5-
6 is required for this to occur (21). Between 10-12 hours post infection B. abortus finally 
begins to replicate in the endoplasmic reticulum-like replicative niche (22) that is rich in 
nutrients and amino acids (23). Over a 48 hour period, Brucella will replicate in the ER-type 
vesicles until the cytoplasm of the cell is filled(21).  Brucella have the ability to replicate 
extensively without disrupting the cellular processes of the host cell while preventing its 
apoptosis (20). Brucella will replicate in this cell until space is no longer available, or 
nutrients become depleted, at which time they will lyse the cell and infect a new cell by an 
unknown mechanism (21). 
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Figure 1.1. Opsonized and non-opsonized Brucella internalization and trafficking in a 
macrophage. Once internalized, Brucella are trafficked through an vesicle sharing markers 
with an early endosome. Later the Brucella are found in a compartment resembling a late 
endosome where a majority of the bacteria will be killed. The surviving bacteria will 
replicate in a vesicle sharing markers with the endoplasmic reticulum. 
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Intracellular lifestyle of opsonized Brucella 
Immunoglobulin opsonized Brucella are internalized by macrophages through 
crosslinking of surface receptors (24). Anti-Brucella antibodies arise rapidly and are easily 
detected by the end of the first week of infection. The presence of antibodies not only 
facilitates antibody mediated complement killing of bacteria in the sera, but also increases 
internalization of the bacteria by monocytes and macrophages through Fc receptors (25). The 
intracellular pathways utilized by B. abortus for survival and replication vary depending on 
the method used for internalization into the host cell (Figure 1.1). As a result, the intracellular 
trafficking of opsonized Brucella differs from that observed for non-opsonized bacteria. 
Within minutes after internalization, opsonized Brucella are found within the early 
endosomal compartment (similar to that observed for non-opsonized) (26) defined by the 
presence of the small GTPase Rab5, early endosomal antigen 1 (EEA1) and the transferrin 
receptor (24). The pH of Brucella containing vesicles changes from ~5.5 of the early 
endosome to pH < 4 by 2 hours post infection with the acquisition of the regulator Rab7 that 
recruits the late endosomal effectors LAMP1, cathepsins (27), vacuolar H+-ATPase and rab7 
interacting lysosomal protein (RILP) (28).  At this stage, 60% of the bacteria are degraded 
(29).  
Brucella virulence, intracellular survival, and replication 
 The low pH of the late endosomal compartment is critical for up-regulation of the virB 
type IV secretion system (22). VirB is required for non-opsonized Brucella that survive 
within the phagolysosome to form a successful intracellular replicative compartment (21). In 
addition to VirB, other B. abortus virulence factors help the pathogen resist degradation 
inside the phagolysosome. One of these mechanisms is the production of periplasmic cyclic 
β-1,2-glucans (21) that disrupt lipid rafts and prevent fusion of Brucella containing vesicles 
with lysosomes (23). Superoxide dismutases sodC and sodA are produced to detoxify O2-, 
and catalases AhpC and KatE protect against H2O2 inside the phagosome (30). This 
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bacterium also employs a urease and a proton symporter, GadC, to resist killing in extremely 
acidic conditions (23).   
The reason Brucella is such a powerful intracellular infectious bacterium is due to its 
ability it evade the host immune system. One such way that Brucella is able to do so is by 
inhibiting the activation of nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF-κB), which usually is responsible for the activation of cytokine production as an 
inflammatory response (31). In addition, Brucella lipoprotein is able to down regulate the 
surface expression of CD64 via TLR2 on the infected host cell (32). This decrease in CD64 
expression restricts Brucella uptake via the FC RI receptor possibly favoring uptake through 
lipid rafts, which seems to lead to a higher survival rate of the bacteria (32). In addition to 
enabling the invasion of Brucella into the host cell, the LPS has little to no endotoxicity and 
is able to down regulate antigen presentation by major histocompatibility complex (MHC) 
class II molecules (21). It does this by blebbing off replicating Brucella in large quantities, 
and then is trafficked through late endosomes, and loaded onto MHC class II molecules and 
displayed on the surface of the host cell (21). The MHC class II molecules displaying the 
Brucella LPS on the surface of the cell form large microdomains called ‘lipid mega rafts’ 
which remain on the surface of the host cell for up to 3 months (21). These mega rafts cause 
a down regulation in antigen presentation via MHC class II resulting in a decrease in 
activation of CD4+ T cells (21). CD4+ T cells are instructed to become a variety of different 
T helper cells by the presence of different cytokines.  T helper-1 cells produce interferon-
gamma (IFN-γ) in response to B. abortus infection (8). IFN-γ is a type II interferon initially 
identified in 1965 for its production in response to viral infections by lymphocytes (33). It is 
produced primarily by natural killer cells and T lymphocytes, and its production is controlled 
by the cytokine IL-12 produced by myeloid cells (33). IFN-γ was shown to be essential for 
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protective immunity against many pathogens (33), and it is the primary activator of 
macrophages (8). 
Interferon mediated anti-Brucella activity  
Interferon gamma is essential for resistance to facultative intracellular bacterial pathogens 
(34). It has been shown to be critical for the control of B. abortus infection in vivo and in 
vitro (8). Aside from CD4+ T cells producing IFN-γ within the host, CD8+ T cells are also 
able to secrete this cytokine, and it is these cells that are critical for the IFN-γ mediated 
immunity against B. abortus infection (8). It was found that pretreatment of mice with a dose 
of IFN-γ prior to infection and two doses of the cytokine post infection greatly decrease the 
bacterial load in the spleen of the infected animals (35). 
LRG-47  
LRG-47 and intracellular defenses 
Interferon gamma induces expression of nearly 1300 genes in the macrophage (36).  
Among this collection of genes is a family of Immunity-Related p47 guanosine triphosphate-
binding proteins (GTPase) comprised of 6 members divided into 2 groups  (37). Group 1 of 
the p47 GTPases contains GTPI (38), IGTP (39), and LRG-47 (37) and is identified as the 
GMS subgroup. Group 2, the GKS subgroup, consists of IRG-47 (40), TGTP/Mg21 (41), and 
IIGP (38). The LRG-47 protein is comprised of 409 amino acids with a predicted molecular 
weight of 46.5 kDa. Expression of LRG-47 is induced by LPS, IFN-γ and IFN-α/β (37). 
Induction of LRG-47 initiates within 2 hours of IFN-γ stimulation and peaks at 8-12 hours 
(37, 42).  
Induction of this family of proteins provides additional protection against intracellular 
infections (41). Interestingly, protection afforded by individual p47 GTPases is pathogen 
specific, whereby a p47 GTPase will inhibit some pathogenic infections but not others. IGTP 
reduces intracellular Toxoplasma gondii  parasite burden, however, does not alter the course 
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of murine cytomegalovirus or Listeria monocytogenes infection (43). Vesicular stomatitis 
virus infection is inhibited by TGTP whereas herpes virus infection and replication are not 
affected. A similar pathogen specific relationship exists for LRG-47.  Infection of LRG-47 
knockout mice with M. tuberculosis (44), L. monocytogenes, and T. gondii led to a higher 
burden of pathogen, however, murine cytomegalovirus infections in the knockout did not 
(45). Pathogen specific protection can also vary between pathogens belonging to the same 
genus. Among pathogenic Chlamydia which share >99% of their predicted open reading 
frames, C. trachomatis infection is controlled by LRG-47 and C. muridarum is not (46). 
LRG-47 mechanism 
LRG-47 has a number of important regulatory functions inside the host cell. The different 
functions of the protein are determined by the different types of structures or organelles that 
have acquired the LRG-47 protein. Association of LRG-47 with cortical, polymerized actin 
coordinately regulates cellular adhesion and motility, as well as phagocytosis of external 
particles, following stimulation of the macrophage with IFN-γ (47). Disruption of membrane 
organization leads to altered vesicle/membrane trafficking within cells (47). LRG-47 
localizes to the cis-Golgi in a nucleotide independent manner, and is recruited to the plasma 
membrane during a phagocytic event that requires GTP binding (42). LRG-47 associates 
with the autophagosome where it stays associated for the entire maturation process and 
eventually colocalizes with LAMP1 (42) (Figure 1.2). This intracellular trafficking is said to 
be directed by an amphipathic helix on the C-terminus of LRG-47, as well as by its G domain 
sequence (42). More LRG-47 is rapidly released by the Golgi and possibly the endoplasmic 
reticulum, and trafficked quickly to the plasma membrane (42). It was later found that LRG-
47 also colocalizes to the trans-Golgi network and is found on acidic vesicles (48). 
Transferrin labeled with a fluorochrome was used to show that LRG-47 was barely 
detectable in early or recycling endosomes (48).  
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Figure 1.2. Autophagy and LRG-47. The process of autophagy from initial generation of the 
phagophore, to complete degradation of the autophagosomal contents. The source of the 
phagophore membrane can be from the nuclear membrane, the golgi apparatus, the 
endoplasmic reticulum, or the mitochondrial membrane as indicated by the arrows. Other 
proteins involved in the elongation of the phagophore membrane not listed on the figure 
include Atg12-Atg5 complex, Atg7-Atg10 complex, and Atg16. Diagram also shows LRG-
47 intracellular localization and involvement in the process of autophagy inside the cell. 
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Humans possess a single p47 GTPase, IRGM1, that is homologous to the p47 GTPases 
found in mice (49). Humans express 5 distinct isoforms of the IRGM protein through splice 
variation of the encoding transcript (50).  Splice variation is hypothesized to provide variable 
functions to IRGM within the cell without encoding for separate p47 GTPases.   
The link between autophagy and LRG-47 was strengthened by the confirmatory findings 
of Gutierrez et al. and their work with the murine monocyte cell line, RAW264.7 (51). Upon 
transfecting RAW264.7 cells with LRG-47, this group observed the formation of 
autophagosomes inside the cells, an effect similar to that seen when macrophages are treated 
with the cytokine IFN-γ (51). Interestingly, LRG-47 positive vesicles became larger, and 
their association with the autophagosome marker LC3 rapidly decreased, though it was clear 
that these organelles were autophagosomes by their 100% colocalization with the acidity 
indicator LysoTracker (51). 
Autophagy 
Introduction 
Autophagy is the process of programmed self-digestion in a cell that recycles amino 
acids, enzyme cofactors, lipids and nucleotides from damaged proteins and organelles. There 
are three types of autophagy that occur in a cell, microautophagy, chaperone-mediated 
autophagy, and macroautophagy (52). Macroautophagy, more commonly known as 
autophagy, is important for degrading protein aggregates, influencing cell death (52), and 
clearing intracellular pathogens (53, 54).  Research to describe the autophagy pathway in 
detail has been performed primarily on the yeast Saccharomyces cerevisiae (55), but the 
pathway is well conserved in mammalian cells (49).  The term ‘autophagy’ was coined by 
Christian de Duve and Robert Wattiaux in their paper describing an intracellular process 
where smooth ER membrane encircled cytoplasmic contents and acquired lysosomal 
hydrolases (56). Other sources of membrane that can incorporate into the autophagosome 
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include the outer mitochondrial membrane (57), the outer nuclear membrane (58), or the 
golgi apparatus (59) (Figure 1.2). Autophagy initiates with a portion of membrane, called the 
phagophore, which expands through the assembly of the multimer complex of autophagy 
related (Atg) proteins Atg 5, 7, 10, and 12 (60, 61).  This complex recruits Atg16 and LC3, a 
microtubule-associated protein light chain 3 (initially identified as Atg8) (62). Within the 
cytosol, nascent LC3 polypeptide (pro-LC3) is cleaved by a specific protease into LC3A (aka 
LC3-I) (62-64). LC3A is converted into LC3B (aka LC3-II), the membrane bound lipidated 
form, through the covalent attachment of phosphotidyl-ethanolamine (PE) (65).  LC3B then 
localizes to the phagophore membrane where it directs development of the phagophore into 
an early autophagosome, an enclosed structure that acquires the early endosomal regulator 
Rab5 (60). Maturation of the early autophagosome into a late autophagosome is carried out 
by Rab5 recruiting and being replaced by Rab7 (66, 67). Rab7 and the recruited effector 
protein, RILP, mediate the subsequent fusion of the late autophagome with lysosomes in a 
microtubule dependent manner to generate the autolysosome (68, 69). With the fusion of 
lysosomes, constituents of the autophagosome including the inner (70) and outer membranes 
(60, 65) are degraded through the combined activity of the vacuolar H+-ATPase (V-ATPase), 
cathepsins D, H, and S, and acid hydrolases (71, 72).  The contents of the autolysosome are 
released into the cytoplasm of the cell, where they are reused in many cellular processes.   
Autophagy activation 
Autophagy is induced in mammalian cells by stress, damage (52), serum starvation (56) 
and amino acid starvation (73). The mammalian-target of rapamycin protein (mTOR), is a 
PI3K-related kinase that signals cell health and promotes cell division (74). Inhibition of 
mTOR by rapamycin (51), simulates amino acid starvation even under nutrient replete 
conditions thereby inducing autophagy. Assembly of the autolysosome is disrupted by the 
PI3K inhibitors, 3-methyladenine (3MA) (75) and wortmannin (76).  Both 3MA and 
wortmannin act by inhibiting type III phosphotidylinositol-3’ kinases (PI3K), cytosolic 
 15  
enzymes required for the early stages of autophagosome development (77).  Acidity of 
autolysosomes can be neutralized by nanomolar concentrations of the V-ATPase specific 
inhibitor, bafilomycin A1 (78). Loss of the proton gradient mutes the degradative activity of 
the autolysosome and prevents additional lysosomes from fusing with the organelle (79).  
Autophagy in macrophages results from the general cell stressors mentioned above, and 
can also be stimulated by exposure to IFN-γ (80). Induction by the pro-inflammatory 
cytokine elevates cellular defenses to protect against intracellular parasitism during infection. 
Activation of autophagy both by IFN-γ and rapamycin is evident by the increase in cellular 
amounts of LC3B (51, 75, 81). In macrophages, autophagy also performs a critical role in 
host innate immunity by sequestering intracellular pathogens that are either free within the 
cytosol or in a membrane bound compartment into an autophagosome (81). Pathogens 
sequestered in this manner will not only be degraded, but the microbial peptides will be 
directed into antigen processing and for MHC class I and class II presentation (82). Should 
the autolysosome disintegrate releasing microbial peptides into the cytosol, the peptides can 
act as targets for the cytosolic proteasome after which they are transported by TAP-1 and -2 
into the ER and loaded onto MHC class I molecules for cross presentation (82). In contrast, 
should the autophagosome/autolysosome modify or fuse with constituents of the MHC class 
II loading compartment, the degraded peptides will serve as a source of antigen for MHC 
class II loading (83). It is in this way that the autophagosomal pathway contributes to antigen 
presentation via MHC molecules. 
Autophagy and disease 
Dysregulation of autophagosomal processes within the cell can be detrimental to the 
health of the host causing a plethora of problems including uncontrolled intracellular 
pathogen infections, a number of neurodegenerative diseases, Huntington’s disease, diabetes, 
aging, muscle atrophy, lipid metabolism, antioxidant response, and different types of  cancer 
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(84).  Of the different types of neurodegenerative diseases caused by the dysregulation of 
autophagy are Alzheimer’s disease and Parkinson’s disease. Alzheimer’s disease is caused by 
a build-up of autophagosomes inside neuronal cells of the brain that contain undigested 
proteins (85). These neurons also contain amyloid-β peptide and extracellular β-amyloid 
deposits in extensive amounts, which is due to the autophagic defect in protein clearance 
(85). Parkinson’s disease, the second most common human neurodegenerative disease, is also 
due to a dysregulation of autophagy processes (86). Parkinson’s disease is caused by an 
accumulation of protein aggregates in the cytoplasm of neuronal tissue cells causing an 
eventual loss of dopaminergic neurons in the brain (86, 87). One major protein that makes up 
the protein aggregates is α-synuclein which was found to inhibit the early stages of 
autophagosome formation, explaining the build-up of protein aggregates inside these tissues 
(86). It was also said that α-synuclein may play a role in lysosome malfunction, causing 
autophagosomes containing undigested protein to build up inside the cell (87). This was 
evidenced by an accumulation of LC3-II protein and an increase in LC3 gene expression in 
the brain tissue of Parkinson’s disease patients (87). As seen by its importance in preventing 
neurological disorders, the process of autophagy is critical for much more than controlling 
intracellular infection. 
 17  
References 
 
1. Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of 
human Brucellosis. Indian J MedMicro 2007;25(3):188-202. 
2. Meyer KF, Shaw EB. A comparison of the morphologic, cultural and biochemical 
characteristics of B. abortus and B.melitensis: Studies on the genus Brucella Nov. 
Gen. I. J InfectDiseas 1920;27(3):173-184. 
3. Buddle MB. Studies on Brucella ovis, a cause of genital disease of sheep in New 
Zealand and Australia. J Hyg-Cambridge 1956;54(3):351-364. 
4. Carmicheal LE, Bruner DW. Characteristics of a newly-recognized species of 
Brucella responsible for infectious canine abortions. Cornell Vet 1968;48(4):579-592. 
5. Stoenner HG, Lackman DB. A new species of Brucella isolated from the desert wood 
rat, Neotoma lepida Thomas. American Journal of Vet Res 1957;18(69):947-951. 
6. Ewalt DR, Payeur JB, Martin BM, Cummins DR, Miller WG. Characteristics of a 
Brucella species from a bottlenose dolphin (Tursiops Truncatus). J Vet Diag Invest 
1994;6(4):448-452. 
7. Ross HM, Jahans KL, MacMillan AP, Reid RJ, Thompson PM, Foster G. Brucella 
species infection in North Sea seal and cetacean populations. Vet Rec 
1996;138(26):647-648. 
8. Carvalho Neta AV, Mol JPS, Xavier MN, Paixão TA, Lage AP, Santos RL. 
Pathogenesis of bovine brucellosis. Vet Journal 2010;184(2):146-155. 
9. Gyles CL, Prescott JF, Songer G, Thoen CO. Brucella. In: Edition t, editor. 
Pathogenesis of Bacterial Infections in Animals Wiley-Blackwell; 2010. p. 429-441. 
10. Sauret JM, Vilissova N. Human brucellosis. J Am Board Fam Pract 2002;15(5):401-
406. 
11. Corbel MJ. Brucellosis: An overview. Emerg Infect Dis 1997;3(2):213. 
12. CDC NCfIaRDDoBD. Brucellosis. 2007  [cited 2011 23 May, 2011]; 
[http://www.cdc.gov/ncidod/dbmd/diseaseinfo/brucellosis_g.htm - istreatment].   
13. Young EJ. An Overview of Human Brucellosis. Clinical Infectious Diseases 
1995;21(2):283-290. 
14. Payne JM. The pathogenesis of experimental brucellosis in the pregnant cow. J Path 
Bact 1959;78:447-463. 
15. Samartino LE, Enright FM. Pathogenesis of abortion of bovine brucellosis. Comp 
Immunol, Micro Infect Diseas 1993;16(2):95-101. 
 18  
16. Poester FP, Gonçalves VSP, Paixão TA, Santos RL, Olsen SC, Schurig GG, Lage AP. 
Efficacy of strain RB51 vaccine in heifers against experimental brucellosis. Vaccine 
2006;24(25):5327-5334. 
17. Pasquevich KA, Ibanez AE, Coria LM, Samartino CG, Estein SM, Zwerdling A, 
Barrionuevo P, Oliveira FS, Seither C, Warzecha H, Oliveira SC, Giambartolomei 
GH, Cassataro J. An oral vaccine based on U-Omp19 induces protection against B. 
abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. 
PLoS ONE 2011;6(1):16203. 
18. Schurig GG, Roop II RM, Bagchi T, Boyle S, Buhrman D, Sriranganathan N. 
Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Micro 
1991;28(2):171-188. 
19. Watarai M, Makino S, Michikawa M, Yanagisawa K, Murakami S, Shirahata T. 
Macrophage plasma membrane cholesterol contributes to Brucella abortus infection 
of mice. Infect Immun 2002;70(9):4818-4825. 
20. Celli J. Surviving inside a macrophage: The many ways of Brucella. Research in 
Micro 2006;157(2):93-98. 
21. Lopez-Goni I, Moriyon I, editors. Brucella, molecular and cellular biology. 
Pamplona: Horizon Bioscience; 2004. 
22. Comerci DJ, Martínez-Lorenzo MJ, Sieira R, Gorvel JP, Ugalde RA. Essential role of 
the VirB machinery in the maturation of the Brucella abortus-containing vacuole. 
Cell Micro 2001;3(3):159-168. 
23. Roop R, Gaines J, Anderson E, Caswell C, Martin D. Survival of the fittest: how 
Brucella strains adapt to their intracellular niche in the host. Med Micro Immunol 
2009;198(4):221-238. 
24. Gorvel JP, Moreno E. Brucella intracellular life: from invasion to intracellular 
replication. Vet Micro 2002;90(1-4):281-297. 
25. Arenas GN, Staskevich AS, Aballay A, Mayorga LS. Intracellular trafficking of 
Brucella abortus in J774 macrophages. Infect Immun 2000;68(7):4255-4263. 
26. Pizarro-Cerda J, Meresse S, Parton RG, van der Goot G, Sola-Landa A, Lopez-Goni 
I, Moreno E, Gorvel JP. Brucella abortus transits through the autophagic pathway 
and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect 
Immun 1998;66(12):5711-5724. 
27. Bellaire BH, Roop RM, II, Cardelli JA. Opsonized virulent Brucella abortus 
replicates within nonacidic, endoplasmic reticulum-negative, LAMP-1-positive 
phagosomes in human monocytes. Infect Immun 2005;73(6):3702-3713. 
 19  
28. Starr T, Ng TW, Wehrly TD, Knodler LA, Celli J. Brucella intracellular replication 
requires trafficking through the late endosomal/lysosomal compartment. Traffic 
2008;9(5):678-694. 
29. Arenas GN, Grilli DJ, Samartino LE, Magadan J, Mayorga LS. Brucella alters 
endocytic pathway in J774 macrophages. Virulence 2010;1(5):376-385. 
30. Roop II RM, Gee JM, Robertson GT, Richardson JM, Ng WL, Winkler ME. Brucella 
stationary-phase gene expression and virulence. Ann Rev Micro 2003;57(1):57-76. 
31. Pei J, Turse JE, Ficht TA. Evidence of Brucella abortus OPS dictating uptake and 
restricting NF-[kappa]B activation in murine macrophages. Microb Infect 
2008;10(6):582-590. 
32. Barrionuevo P, Delpino MV, Velásquez LN, García Samartino C, Coria LM, Ibañez 
AE, Rodríguez ME, Cassataro J, Giambartolomei GH. Brucella abortus inhibits IFN-
[gamma]-induced Fc[gamma]RI expression and Fc[gamma]RI-restricted 
phagocytosis via toll-like receptor 2 on human monocytes/macrophages. Microbes 
Infect 2011;13(3):239-250. 
33. Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A, Picard C, 
Abel L, Jouanguy E, Casanova JL. Inborn errors of interferon mediated immunity in 
humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-
lambda in host defense. Immunol Rev 2008;226:29-40. 
34. Zhan Y, Cheers C. Endogenous gamma interferon mediates resistance to Brucella 
abortus infection. Infect Immun 1993;61(11):4899-4901. 
35. Stevens MG, Pugh GW, Jr, Tabatabai LB. Effects of gamma interferon and 
indomethacin in preventing Brucella abortus infections in mice. Infect Immun 
1992;60(10):4407-4409. 
36. Ehrt S, Schnappinger D, Bekiranov S, Drenkow J, Shi S, Gingeras TR, Gaasterland T, 
Schoolnik G, Nathan C. Reprogramming of the macrophage transcriptome in 
response to interferon-gamma and Mycobacterium tuberculosis. J Exp Med 
2001;194(8):1123-1140. 
37. Sorace JM, Johnson RJ, Howard DL, Drysdale BE. Identification of an endotoxin and 
IFN-inducible cDNA: possible identification of a novel protein family. J Leukoc Biol 
1995;58(4):477-484. 
38. Boehm U, Guethlein L, Klamp T, Ozbek K, Schaub A, Fatterer A, Pfeffer K, Howard 
JC. Two families of GTPases dominate the complex cellular response to IFN-gamma. 
J Immunol 1998;161(12):6715-6723. 
 20  
39. Taylor GA, Jeffers M, Largaespada DA, Jenkins NA, Copeland NG, Woude GFV. 
Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates 
in response to interferon gamma. J Biol Chem 1996;271(34):20399-20405. 
40. Gilly M, Wall R. The IRG-47 gene is IFN-gamma induced in B cells and encodes a 
protein with GTP-binding motifs. J Immunol 1992;148(10):3275-3281. 
41. Carlow DA, Teh S, Teh H. Specific antiviral activity demonstrated by TGTP, a 
member of a new family of interferon-induced GTPases. J Immuno 1998;161:2348-
2355. 
42. Martens S, Sabel K, Lange R, Uthaiah R, Wolf E, Howard JC. Mechanisms 
regulating the positioning of mouse p47 resistance GTPases LRG-47 and IIGP1 on 
cellular membranes: Retargeting to plasma membrane induced by phagocytosis. J 
Immunol 2004;173(4):2594-2606. 
43. Taylor GA, Collazo CM, Yap GS, Nguyen K, Gregorio TA, Taylor LS, Eagleson B, 
Secrest L, Southon EA, Reid SW, Tessarollo L, Bray M, McVicar DW, Komschlies 
KL, Young HA, et al. Pathogen-specific loss of host resistance in mice lacking the 
IFN-gamma-inducible gene IGTP. PNAS 2000;97(2):751-755. 
44. MacMicking JD, Taylor GA, McKinney JD. Immune control of Tuberculosis by IFN-
gamma-inducible LRG-47. Science 2003;302(5645):654-659. 
45. Collazo CM, Yap GS, Sempowski GD, Lusby KC, Tessarollo L, Woude GF, Sher A, 
Taylor GA. Inactivation of LRG-47 and IRG-47 reveals a family of interferon 
gamma-inducible genes with essential, pathogen-specific roles in resistance to 
infection. J Exp Med 2001;194(2):181-188. 
46. Coers J, Bernstein-Hanley I, Grotsky D, Parvanova I, Howard JC, Taylor GA, 
Dietrich WF, Starnbach MN. Chlamydia muridarum evades growth restriction by the 
IFN-{gamma}-inducible host resistance factor Irgb10. J Immunol 2008;180(9):6237-
6245. 
47. Henry SC, Daniell X, Indaram M, Whitesides JF, Sempowski GD, Howell D, Oliver 
T, Taylor GA. Impaired macrophage function underscores susceptibility to 
Salmonella in mice lacking Irgm1 (LRG-47). J Immuno 2007;179(10):6963-6972. 
48. Zhao YO, Konen-Waisman S, Taylor GA, Martens S, Howard JC. Localisation and 
mislocalisation of the interferon-inducible immunity-related GTPase, Irgm1 (LRG-
47) in mouse cells. PLoS ONE 2010;5(1):8648. 
49. Tian Y, Li Z, Hu W, Ren H, Tian E, Zhao Y, Lu Q, Huang X, Yang P, Li X, Wang X, 
Kovács AL, Yu L, Zhang H. C. elegans screen identifies autophagy genes specific to 
multicellular organisms. Cell 2010;141(6):1042-1055. 
 21  
50. Bekpen C, Xavier R, Eichler E. Human IRGM gene “to be or not to be”. Semin 
Immunopathol 2010:1-8. 
51. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. Autophagy 
is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in 
infected macrophages. Cell 2004;119(6):753-766. 
52. Liu CL, Chen S, Dietrich D, Hu BR. Changes in autophagy after traumatic brain 
injury. J Cere Bl Flow & Meta 2008;28:674-683. 
53. McPhee CK, Baehrecke EH. Autophagy shows its animal side. Cell 2010;141(6):922-
924. 
54. Ogawa M, Sasakawa C. Bacterial evasion of the autophagic defense system. Curr 
Opin Microbiol 2006;9(1):62-68. 
55. Tsukada M, Ohsumi Y. Isolation and characterization of autophagy-defective mutants 
of Saccharomyces cerevisiae. FEBS Letters 1993;333(1-2):169-174. 
56. de Duve C, Wattiaux R. Functions of lysosomes. Ann Rev Phys 1966;28(1):435-492. 
57. Hailey DW, Rambold AS, Satpute-Krishnan P, Mitra K, Sougrat R, Kim PK, 
Lippincott-Schwartz J. Mitochondria supply membranes for autophagosome 
biogenesis during starvation. Cell 2010;141(4):656-667. 
58. English L, Chemali M, Duron J, Rondeau C, Laplante A, Gingras D, Alexander D, 
Leib D, Norbury C, Lippe R, Desjardins M. Autophagy enhances the presentation of 
endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat 
Immunol 2009;10(5):480-487. 
59. Geng J, Klionsky DJ. The Golgi as a potential membrane source for autophagy. 
Autophagy 2010;6(7):950-951. 
60. Reggiori F, Klionsky DJ. Autophagosomes: biogenesis from scratch? Curr Opin Cell 
Biol 2005;17(4):415-422. 
61. Xie Z, Nair U, Klionsky DJ. Atg8 controls phagophore expansion during 
autophagosome formation. Mol Biol Cell 2008;19(8):3290-3298. 
62. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, 
Ohsumi Y, Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized 
in autophagosome membranes after processing. EMBO J 2000;19(21):5720-5728. 
63. Liu CL, Chen S, Dietrich D, Hu BR. Changes in autophagy after traumatic brain 
injury. J Cerebr Blood F Met 2008;28:674-683. 
64. Yoshimura K, Shibata M, Koike M, Gotoh K, Fukaya M, Watanabe M, Uchiyama Y. 
Effects of RNA interference of Atg4B on the limited proteolysis of LC3 in PC12 cells 
and expression of Atg4B in various rat tissues. Autophagy 2006;2(3):200-208. 
 22  
65. Yoshimori T. Autophagy: a regulated bulk degradation process inside cells. Biochem 
Bioph Res Co 2004;313(2):453-458. 
66. Flinn RJ, Yan Y, Goswami S, Parker PJ, Backer JM. The late endosome is essential 
for mTORC1 signaling. Mol Biol Cell 2010;21(5):833-841. 
67. Pankiv S, Alemu EA, Brech A, Bruun JA, Lamark T, Overvatn A, Bjorkoy G, 
Johansen T. FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate 
microtubule plus end-directed vesicle transport. J Cell Biol 2010;188(2):253-269. 
68. Jager S, Bucci C, Tanida I, Ueno T, Kominami E, Saftig P, Eskelinen EL. Role for 
Rab7 in maturation of late autophagic vacuoles. J Cell Sci 2004;117(20):4837-4848. 
69. Longatti A, Tooze SA. Vesicular trafficking and autophagosome formation. Cell 
Death Differ 2009;16(7):956-965. 
70. Gutierrez MG, Munafo DB, Beron W, Colombo MI. Rab7 is required for the normal 
progression of the autophagic pathway in mammalian cells. J Cell Sci 
2004;117(13):2687-2697. 
71. Dorn BR, Dunn Jr. WA, Progulske-Fox A. Bacterial interactions with the autophagic 
pathway. Cell Microbiol 2002;4(1):1-10. 
72. Lee J, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-
Vicente M, Massey AC, Sovak G, Uchiyama Y, Westaway D, Cuervo AM, Nixon 
RA. Lysosomal proteolysis and autophagy require Presenilin 1 and are disrupted by 
Alzheimer-related PS1 mutations. Cell 2010;In Press, Corrected Proof. 
73. Mortimore GE, Hutson NJ, Surmacz CA. Quantitative correlation between 
proteolysis and macro- and microautophagy in mouse hepatocytes during starvation 
and refeeding. Proceed Nat Acad Sci 1983;80(8):2179-2183. 
74. Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y. Tor-mediated 
induction of autophagy via an Apg1 protein kinase complex. J Cell Biol 
2000;150(6):1507-1513. 
75. Mitroulis I, Kourtzelis I, Kambas K, Rafail S, Chrysanthopoulou A, Speletas M, Ritis 
K. Regulation of the autophagic machinery in human neutrophils. Eur J Immunol 
2010;40(5):1461-1472. 
76. Walker S, Chandra P, Manifava M, Axe E, Ktistakis NT. Making autophagosomes. 
Autophagy 2008;4(8):1093-1096. 
77. Petiot A, Ogier-Denis E, Blommaart EFC, Meijer AJ, Codogno P. Distinct classes of 
phosphatidylinositol 3-kinases are involved in signaling pathways that control 
macroautophagy in HT-29 cells. J Biol Chem 2000;275(2):992-998. 
 23  
78. Sobota JA, Back N, Eipper BA, Mains RE. Inhibitors of the V0 subunit of the 
vacuolar H+-ATPase prevent segregation of lysosomal- and secretory-pathway 
proteins. J Cell Sci 2009;122(19):3542-3553. 
79. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y. 
Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion 
between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. 
Cell Struct Func 1998;23:33-42. 
80. Feng CG, Zheng L, Lenardo MJ, Sher A. Interferon-inducible immunity-related 
GTPase Irgm1 regulated IFN-gamma dependent host defense, lymphocyte survival 
and autophagy. Autophagy 2009;5(2):232-234. 
81. Lerena MC, Vázquez CL, Colombo MI. Bacterial pathogens and the autophagic 
response. Cell Micro 2010;12(1):10-18. 
82. Chemali M, Radtke K, Desjardins M, English L. Alternative pathways for MHC class 
I presentation: a new function for autophagy. Cell and Molec Life Sci 
2011;68(9):1533-1541. 
83. Munz C. Antigen processing for MHC presentation by autophagy. F1000 Biol Rep 
2010;2(61):1-4. 
84. Deretic V. Autophagy in immunity and cell-autonomous defense against intracellular 
microbes. Immunol Rev 2011;240(1):92-104. 
85. Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, Schmidt SD, 
Wesson DW, Bandyopadhyay U, Jiang Y, Pawlik M, Peterhoff CM, Yang AJ, Wilson 
DA, St. George-Hyslop P, et al. Therapeutic effects of remediating autophagy failure 
in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis. 
Autophagy 2011;7(7):1-2. 
86. Winslow AR, Rubinsztein DC. The Parkinson disease protein alpha-synuclein 
inhibits autophagy. Autophagy 2011;7(4):429-431. 
87. Wu G, Wang X, Feng X, Zhang A, Li J, Gu K, Huang J, Pang S, Dong H, Gao H, 
Yan B. Altered expression of autophagic genes in the peripheral leukocytes of 
patients with sporadic Parkinson's disease. Brain Res 2011;1394:105-111. 
 
 
 
 
 
 
24  
CHAPTER 2. HOST INTERFERON-γ INDUCIBLE PROTEIN CONTRIBUTES TO 
BRUCELLA SURVIVAL 
 
 
A paper to be submitted 
 
 
Jennifer A. Ritchie1, James A. Cardelli2, and Bryan H. Bellaire1 
 
 
1Department of Veterinary Microbiology and Preventive Medicine 
Iowa State University, College of Veterinary Medicine, 
Ames, IA. 
 
2Department of Microbiology and Immunology, Louisiana State University Health Sciences 
Center – Shreveport, Shreveport, LA. 
 
 
 
Abstract 
Brucella spp. are highly adapted intracellular parasites of mammals that cause chronic 
infections while surviving and replicating in host monocytes and macrophages. Although 
monocytes are normally susceptible to infection, a newly discovered host defense mechanism 
combats infection by altering the intracellular replication of pathogens persisting within cells 
following stimulation of host cells with pro-inflammatory cytokine interferon-γ (IFN-γ). We 
examined the contribution of the IFN-γ inducible GTPase, LRG-47, to Brucella abortus 2308 
infection in in vitro and in vivo murine models. Infecting macrophages harvested from LRG-
47-/- mice revealed that loss of this host protein negatively affected the intracellular survival 
and replication of IgG opsonized B. abortus while the viability of non-opsonized bacteria 
was similar to levels seen with similarly treated C57/B6 macrophages. This opsonization 
dependent effect was reversed in LRG-47 cells by pre-stimulating LRG-47-/- macrophages 
with IFN-γ as observed by a severe defect in Brucella survival of non-opsonized bacteria and 
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a stimulation of Brucella replication of IgG opsonized bacteria. The requirement for LRG-47 
for B. abortus survival and replication in murine macrophages is unlike any other pathogen 
studied and provides interesting insight into the complex interaction between Brucella and 
their host.  
 
Introduction 
Brucella spp. are highly infectious intracellular pathogens that establish chronic 
infections by surviving and replicating within host monocytes and macrophages. 
Production of pro-inflammatory cytokines by the host stimulates phagocytosis and killing 
of pathogenic microbes. In vivo and in vitro experiments demonstrate that the most potent 
inducer of anti-Brucella activity in monocytes and macrophages is type II interferon (IFN-
γ) (1). IFN-γ stimulation of monocytes and macrophages increases production of reactive 
oxygen and nitrogen species.  In the case of Brucella abortus, reactive oxygen intermediate 
(ROI) production was found to play a larger role in intracellular resistance to the bacteria 
than nitric oxide (NO) (2), while Brucella suis infected monocytes reduced bacterial load 
primarily through inducible nitric oxide synthase (iNOS) activity (3). Interestingly, 
pretreatment of monocytes with the cytokine IFN-γ yielded the strongest anti-Brucella 
activity.  This activity was characterized as a bacteriostatic mechanism that prevented 
intracellular replication of the Brucella spp. rather than simply increasing killing (2). 
Human T-cells respond to Brucella spp. by stimulating interleukin (IL)-2 production, 
whereby increasing IFN-γ release (4). It was shown by Stevens et al. that intraperitoneal 
injection of recombinant murine IFN-γ into mice significantly lowered the number of B. 
abortus isolated from the spleen at day 7 (IFN-γ was delivered 1 day prior and 2 and 4 days 
post infection).  This increase in resistance to B. abortus was amplified by co-
administration with the cyclooxygenase inhibitor, indomethacin, which blocks 
prostaglandin E2 (PGE2), thereby increasing IL-12 and IFN-γ production (5). Murine 
 
 
26  
macrophages infected with B. abortus secrete IFN-γ, and inactive forms of IL-12, while B. 
abortus lipopolysccharide (LPS) treated monocytes produce IFN-γ and active IL-12 (6). 
Hoover et al. demonstrated that IFN-γ treatment did not stimulate Brucella killing, 
although intracellular replication of opsonized and non-opsonized B. abortus was 
significantly reduced in cultures treated with the cytokine (7).  As confirmed by the 
literature, the restriction in intracellular replication of Brucella involves more than the NO 
and ROI generating mechanisms of the host cell.  
Recently, a family of Immunity-Related p47 GTPases (IRG) has been identified whose 
activities are strongly induced from undetectably low resting levels (8) by the cytokine 
IFN-γ (9). This 47 to 48 kDa family of proteins, which was first identified in the mouse, is 
divided into two groups based on sequence homology of their G1 motif (8, 10).  Group I 
p47s (GMS) consists of interferon gamma-induced GTPase (IGTP) (Irgm3), GTPI (Irgm2) 
and LRG-47 (Irgm1). Group II (GKS) includes IRG-47 (Irgd), TGTP/Mg21 (Irgb6) and 
IIGP (Irga6) (10).  These two groups of proteins do not act independently but 
interdependently to control intracellular and extracellular pathogen invasion (10).  The 
GMS proteins function as regulators of the GKS proteins’ GTPase cycle, acting as 
attenuators by preventing premature activation of the GKS proteins (11, 12).  These IRG 
proteins have pathogen specific behavior; each protein is involved in controlling a specific 
pathogen (8, 10, 13).  The recent discovery and characterization of these IFN-γ inducible 
proteins reveals that the intracellular environment within monocytes is substantially altered 
in response to IFN-γ to defend against intracellular pathogens. Recent data indicated that 
LRG-47 is essential in macrophage resistance to a variety of intracellular pathogens such as 
Toxoplasma cruzi (14), Toxoplasma gondii (13, 15), Listeria monocytogenes (15), 
Mycobacterium avium (16), Mycobacterium tuberculosis (17), and Chlamydia trachomatis 
(18).  LRG-47 is normally associated with the cis- and medial-golgi network inside a 
macrophage (8, 13, 19).  Upon actin remodeling and phagocytosis, LRG-47 is recruited to 
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phagocytic cups on the plasma membrane, where it will stay for the full life cycle of the 
phagosomal compartment (8).  Since this IRG protein remains associated with the 
phagosomal membrane upon association with a lysosome, LRG-47 is found to colocalize 
with the lysosome associated membrane protein LAMP1 (8, 19), and the acidic vesicle 
stain LysoTracker® inside macrophages (19).  Zhao et al. speculated that the golgi-
localized LRG-47 is the GDP bound form (inactive protein), where as the lysosome-
associated LRG-47 is the GTP bound form (active protein) (19).  It is noted by Hunn et al., 
and MacMicking et al. that LRG-47 binds Mycobacterium containing vacuoles where it 
accelerates fusion with the lysosome, whereby controlling pathogen replication and 
survival.  Pathogen load in the host cell can also be controlled by enhancement of the 
formation of autophagosomes (12, 20) and by promotion of phagosome acidification by 
LRG-47.  LRG-47 deficient mice infected with M. tuberculosis have an increased bacterial 
burden and tissue damage within their lung tissue as compared to a wild-type mouse (36).  
The susceptibility was traced to a deficiency in phagosome maturation; stimulated 
macrophages from LRG-47 knockout mice failed to acidify Mycobacterium-containing 
phagosomes (17). It has been hypothesized that LRG-47 regulates an alternative pathway 
for delivery of proteins from the trans-golgi network (TGN). This pathway may aid the 
host cell in overcoming attempts by pathogens to inhibit phagosome-lysosome fusion (21). 
To our knowledge, there have been no studies relating the changes in Brucella trafficking 
to the decrease in intracellular viability induced by IFN-γ stimulation.   
Prior work in our laboratory has revealed that the type of intracellular replicative niche 
that Brucella occupies depends on how the bacteria were internalized.  In the absence of 
opsonin, Brucella are internalized into vesicles through a process that is dependent on lipid 
raft aggregation at the plasma membrane prior to uptake. In contrast, opsonization of 
Brucella with specific immunonoglobulin directs internalization through an Fc receptor-
dependent process.  Opsonized bacteria were found to replicate within modified endosomes 
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that were non-acidic, and indicated a lack of fusion with a lysosome. Since the activity of 
individual IFN-γ induced proteins is associated with their intracellular localization within 
the cell, both opsonized and nonopsonized bacteria were examined in the following 
experiments to determine whether different intracellular niches were uniquely sensitive to 
specific IFN-γ induced anti-Brucella activities. 
 
Materials and Methods 
Bacterial culture 
Virulent B. abortus laboratory strain 2308 cultures were grown on Trypticase Soy agar 
(Difco) supplemented with 5% bovine blood (BA) (Gemini Bioproducts) under 5% CO2 at 
37oC.  A GFP-expressing derivative of B. abortus 2308 was constructed in prior studies (22) 
by introducing the plasmid pBBR1MCS6-Y encoding GFP expression downstream of the 
constitutively active promoter for aph3A-derived from pBlueKS+Kan (Stratagene) (23). GFP 
positive Brucella were maintained in culture using a concentration of 6 μg/ml 
chloramphenicol.  Heat killed B. abortus cells were prepared by incubating cell suspensions 
at 70ºC for 30 min. Loss of viability was confirmed by plating portions of the heated cell 
suspension on BA and subsequent incubation at 37ºC for four days. All chemicals were 
obtained from Sigma-Aldrich unless otherwise stated. 
Culture of murine bone marrow derived monocytes and RAW264.7 monocytic cells  
Mice were euthanized by halothane overdose prior to removal of the long bones of the 
legs. Marrow was flushed out using a pre-filled 5 cc syringe with 5 mL DMEM and a 26-G 
needle. Cells were pelleted from marrow wash solution by centrifugation and resuspended in 
DMEM + 10% FBS supplemented with 1000 units/ mL M-CSF and incubated for 24 hrs at 
37oC with 5% CO2.  Non-adherent cells were transferred to a 75 cm2 tissue culture flask with 
10 ml DMEM and 1000 units/ mL M-CSF. After 7 days of culture, cells were plated for 
experimental use.  
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Low passage RAW 264.7 (ATCC #TIB-71) were routinely cultured in RPMI 1640 
medium with 2 mM glutamine supplemented with 1.5 g/ml sodium bicarbonate (Mediatech) 
and 10% fetal bovine serum (Gemini Bioproducts). Cells were seeded into both 24 and 96 
well plates at a density of 1 x 105 cells/ml 24 hrs prior to infection. Cell culture viability was 
monitored in suspension by hemocytometer-trypan blue dye exclusion. 
Assessing intracellular survival and replication of B. abortus 
Bacterial suspensions were generated by scraping 48 hour cultures of the B. abortus 
strains grown on BA into screw cap microfuge tubes containing phosphate buffered saline 
(PBS).  Escherichia coli cultures were grown on TSA media for 24 hrs prior to harvesting.  
Pellets of bacteria were resuspended by vigorous vortexing and numbers of bacteria present 
in the suspensions were determined by OD600 measurements.  Bacterial suspensions were 
diluted to desired concentrations in complete RPMI 1640 medium and split into two aliquots 
where one received nonagglutinating concentrations of 1/2500 – 1/5000 of anti-Brucella IgG 
antibody (Difco) to opsonize bacteria (opsonized), and the other received the same volume of 
PBS to serve as a mock control (non-opsonized). Bacterial cell suspensions and antisera were 
incubated at room temperature for 30 min. followed by brief vortexing. Bacteria were added 
to monocyte monolayers treated as described above but plated into 96 well plates at a 
multiplicity of infection (bacteria to monocyte ratio) of 20:1 for opsonized and 100:1 for non-
opsonized Brucella. Due to anticipated differences for internalization kinetics of opsonized 
and nonopsonized bacteria, synchronized internalization was achieved by cooling infected 
cultures to 4ºC followed by 10 min. centrifugation at 270 x g. Monolayers were washed 
gently with cold PBS to remove non-adherent bacteria.  Phagocytosis of adherent bacteria 
was initiated by the addition of fresh pre-warmed media after which cells were incubated for 
20 min. at 37ºC / 5% CO2.  After incubation, cultures were washed 3 times with cold PBS 
and fresh media containing 100 µg/ml gentamicin was added to cells for 1 hour to kill 
adherent but not internalized bacteria.  After one hour antibiotic treatment, media was 
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removed and replaced with fresh media containing 10 µg/ml gentamicin.  Cells remained in 
this medium for the duration of the experiment. Viability of intracellular Brucella was 
determined by lysing monocytes with 0.1% deoxycholate, diluting suspensions in PBS, and 
plating aliquots in triplicate on BA medium (24). Percent survival of bacteria at 24 and 48 hrs 
were calculated based on the number of internalized bacteria detected at 1 hour post infection 
which represents 100% of internalized bacteria. Statistical comparisons were made using the 
Student’s t-test. 
Antibodies and reagents for fluorescence microscopy 
Infected monolayers were prepared for immunofluorescence microscopy at indicated 
times post infection using methods described previously (22). Infected monolayers were 
fixed by incubating coverslips for 20 min. with 4% paraformaldehyde/PBS solution at room 
temperature. Samples were washed with PBS and monolayers were permeabilized and 
stained with antibody in 0.25% bovine serum albumin/PBS solution containing a final 
concentration of 0.1% saponin (BSP). Incubations with primary and secondary antibodies 
were at room temperature on a shaking platform for 1 hour. Primary antibodies were diluted 
in BSP and incubated with fixed Brucella infected cells at the following concentrations: 1/50 
mouse anti-LAMP 1 monoclonal (ID4B- Iowa Hybridoma), 1/5 anti-mannose-6-phosphate 
receptor (Iowa Hybridoma); 1/100 mouse anti-EEA1, anti-calnexin, anti-BiP/GRP74, anti-
p115, anti-p230, anti-SRP54, anti-Rab5 (Transduction Laboratories), mouse anti-transferrin 
receptor (Molecular Probes), rabbit and mouse anti-Cathepsin D (Oncogene). Coverslips 
were washed 3 times with cold BSP and affixed to glass slides with ProLong® Gold 
Antifade reagent plus DAPI stain mounting solution (Invitrogen). Acidic vesicles were 
visualized by incubating cultures with 1/1000 Lysotracker® DND-99 for 10 min. Secondary 
antibodies conjugated with fluorochromes indicated in text were purchased from Jackson 
Immunoresearch (WestGrove, PA).  Immunofluorescence microscopy was performed using 
an Olympus IX-71 epifuorescence microscope with appropriate DAPI/GFP/TRITC filter sets 
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and image processing was performed with ImageJ v1.33g 
(http://rsb.info.nih.gov/ij/index.html). 
 
Results 
Expression and localization of LRG-47 to Brucella-containing vesicles 
To determine if LRG-47 is found on Brucella-containing phagosomes in IFN-γ activated 
monocytes, RAW264.7 cells pre-treated with IFN-γ and infected with opsonized GFP-
expressing-B. abortus were fixed at 18 hrs post infection and immunostained for LRG-47. 
This revealed that individual Brucella within these cells did colocalize with LRG-47 (Figure 
2.1).  Similar results were also obtained with IFN-γ activated peritoneal macrophages (data 
not shown). 
 
Figure 2.1. Brucella abortus containing phagosomes acquire the IFN-γ inducible protein 
LRG-47. Monolayers of RAW264.7 cells were stimulated with IFN-γ, infected with 
opsonized-B. abortus 2308 fixed 18 hrs post infection and stained to visualize the spatial 
relationship of the LRG-47 with the host cell (red). Brucella were observed almost 
exclusively as isolated bacteria within phagosomes positive for LRG-47 (arrow heads). Panel 
of images shown are representative of results from 3 separate experiments (bar = 5 µm).  
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Constitutive expression of LRG-47 does not alter the course of in vitro Brucella 
infection 
Since LRG-47 is induced by IFN-γ and can be localized to Brucella-containing 
phagosomes in these cells, we postulated that LRG-47 had a role in limiting the intracellular 
growth of the bacteria. This notion was examined by generating stable RAW264.7 cells that 
constitutively overexpressed a FLAG tagged LRG-47 fusion protein. The distribution pattern 
of the LRG-47-Flag protein in non-IFN-γ activated cells was indistinguishable from that of 
endogenous LRG-47 in nontransformed IFN-γ treated RAW264.7 cells (data not shown). 
Overexpressing cells were infected with opsonized Brucella in the absence of exogenous 
IFN-γ treatment, and the intracellular viability of the bacteria was followed over 48 hrs post 
infection. CFU’s recovered from 2, 12, 24 and 48 hrs post infection revealed that intracellular 
survival of B. abortus was not affected by constitutive expression of LRG-47 while 
significant reduction in intracellular viability was observed in IFN-γ treated RAW264.7 cells 
(Figure 2.2). The results clearly show that IFN-γ induced anti-Brucella activity was not 
evoked within cells simply overexpressing LRG-47. Although long term intracellular 
survival was not reduced by LRG-47 overexpression, the level of Brucella in these cells was 
more similar to IFN-γ treated cells than non-IFN-γ treated controls up to 24 hrs post 
infection. These observations suggest a possible role for LRG-47 in opsonized Brucella 
internalization and early survival; however, LRG-47 does not limit bacterial replication by 
itself. 
LRG-47 has a positive role in Brucella’s residence in murine monocytes  
Since the overexpression of LRG-47 alone did not affect the viability of Brucella within 
monocytes, we wanted to examine if the loss of this host protein would upset the ability of 
IFN-γ to induce an anti-Brucella activity by monocytes. It was anticipated that macrophages 
from LRG-47-/- mice would be defective to some degree in their IFN-γ induced anti-Brucella 
activity while nonstimulated macrophages would behave similarly to nonactivated cells from 
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normal mice. Intracellular viability of Ig-opsonized Brucella in peritoneal macrophages 
isolated from C57/B6 and LRG47-/- were compared in the presence or absence of IFN-γ 
stimulation (Figure 2.3). Interestingly, significantly fewer viable Brucella were recovered 
from LRG47-/- cells compared to similarly treated C57/B6 cultures, including non-IFN-γ 
treated cultures. At 48 hrs, the number of bacteria recovered from IFN-γ treated LRG47-/- 
cultures increased from 24 hour values, suggesting that some degree of intracellular bacterial 
replication does occur. By contrast, both Brucella survival (CFU at 24 hr) and replication 
(CFU at 48 hr) were significantly reduced in nonstimulated LRG-47-/- cells, suggesting that 
the IFN-γ inducible protein contributed to intracellular bacterial survival. Repeat experiments 
with nonstimulated peritoneal and BMDM macrophages showed similar reductions in 
replication of opsonized Brucella within monocytes from LRG-47-/- mice. 
 
Figure 2.2. Constitutive expression of LRG-47 aids in bacteria replication and survival. 
RAW264.7 murine macrophages stabley transfected with Flag-tagged LRG-47 (Raw264.7 
LRG) were infected with virulent B. abortus. Colony forming units/ml were enumerated at 
0.5, 1, 24, and 48 hrs post infection and compared with the CFU/ml values for non-activated 
RAW264.7 cells (Raw264.7) and IFN-γ activated RAW264.7 cells (Raw264.7 IFN) both of 
which are not overexpressing the LRG-47 protein. (Student’s T test p values * < 0.05, ** < 
0.01). 
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Figure 2.3. Intracellular viability of Brucella in peritoneal macrophages harvested from 
C57/Black6 and LRG47 knockout mice. IFN-γ was added 24 hrs prior to infection with 
immunoglobulin opsonized B. abortus 2308. Means and standard deviations were calculated 
from triplicate samples (** p ≤ 0.01 Student’s t-Test).  Results shown are representative of 3 
independent experiments demonstrating similar significant differences. 
 
Survival and replication of Brucella within RAW264.7 cells and IFN-γ activated cells 
Bacteria opsonized by serum components are internalized faster with greater efficiency a 
non-opsonized bacteria. Cell surface receptors that mediate internalization of opsonized 
particles influence the intracellular trafficking of the new phagosomes through their 
cytoplasmic domains (25). Previous studies determined that immunoglobulin opsonized B. 
abortus localized to a replicative compartment that lacked ER components (22). In contrast, 
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non-opsonzied B. abortus did localize to an ER positive compartment as others have reported 
(26). Thus, the intracellular fate of Brucella depends on the context by which the bacteria are 
presented to monocytes. To determine if the mode of Brucella uptake altered the subsequent 
fate of these bacteria, we performed an intracellular viability experiment with RAW264.7 
cells infected with either IgG opsonized or non-opsonized virulent B. abortus 2308 
employing increasing MOIs. Numbers of intracellular Brucella recovered at 24 and 48 hrs 
were largely in proportion to the number of bacteria internalized at the beginning of the 
experiment (Figure S2.1).  Comparing the groups receiving opsonized bacteria, an identical 
number of internalized bacteria were seen with MOI’s of 20:1 for opsonized and 100:1 for 
non-opsonized. Interestingly, the calculation of survival of Brucella at 48 hrs as a percentage 
of the number of bacteria initially internalized revealed that the replication of 20:1 opsonized 
(1236.4% ± 15.6%) was double that of 100:1 non-opsonized (600.0% ± 1.3%). Considering 
these results, future experiments maintained MOI’s of 20:1 for opsonized and 100:1 for non-
opsonized to maintain consistency in the number of internalized bacteria.  
To determine if IFN-γ treatment was equally effective for opsonized and non-opsonized 
bacteria, intracellular viability experiments were performed with RAW264.7 cells stimulated 
24 hrs prior to infection with 50 U/ml of recombinant IFN-γ (IFN-γ). Similar degrees of IFN-
γ anti-Brucella activity were observed at 24 hrs and 48 hrs post infection and did not differ 
among opsonized or non-opsonized bacteria (Figure S2.2).  Treatment of monocytes with 
IFN-γ resulted in an approximate 2 log reduction in both opsonized and non-opsonized 
bacteria by 24 hrs, and reduced the number of Brucella recovered at 48 hrs down to the limit 
of detection. The calculation of percent survival did not uncover any additional significant 
findings. It is of note that pretreatment of monocytes with IFN-γ did increase the number of 
non-opsonized bacteria internalized 2.5 fold over any other group examined, including the 
20:1 opsonized bacteria in IFN-γ treated cells.  
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Effect of opsonization on Brucella survival 
An earlier report by our laboratory showed that intracellular localization of Brucella 
depended on how the bacteria were initially internalized by the host cell. Those results 
revealed that non-opsonized bacteria replicated in human cells in an intracellular 
compartment resembling the endoplasmic reticulum. Others have demonstrated Brucella 
trafficking through autophagosomes before reaching their replicative compartment (27). By 
contrast, Ig opsonized bacteria replicated in modified late-endosomes and do not traffic 
through an autophagosomal compartment. Since opsonized and non-opsonized bacteria differ 
in their interactions with autophagosomes, we wanted to explore whether the survival of 
Brucella varied in LRG-47-/- cells in response to varying the method of bacterial 
internalization. Comparisons between non-stimulated (resting) and IFN-γ stimulated 
(activated) cells isolated from either B6 or LRG-47-/- mice were carried out using optimal 
MOI’s of 20:1 for Ig-opsonized and 100:1 for non-opsonized, yielding equivalent numbers of 
internalized bacteria within RAW264.7 cells. Infected peritoneal macrophages from wild 
type C57/B6 mice treated with IFN-γ exhibited significant and equal anti-Brucella activity 
against both opsonized and non-opsonized Brucella. In contrast, Brucella viability in LRG-
47 -/- cells was dependent on the whether the bacteria were opsonized, and on the presence of 
IFN-γ activation (Table 2.1).  Resting LRG-47 deficient macrophages harbored significantly 
more non-opsonized Brucella at 48 hrs (137.2 % ± 12.1%) than Ig-opsonized (79.4% ± 
15%). In addition, Ig-opsonized Brucella survival in LRG-47 KO was significantly lower 
than was seen in resting B6 isolated macrophages (114% ± 2.7%). An inverse relationship 
was seen between Brucella survival and the affects of opsonization in IFN-γ stimulated-
LRG-47 KO macrophages (Figure S2.3). Percent survival of non-opsonized Brucella 
dropped dramatically in IFN-γ activated LRG47-/- cells to 32.6% while Ig- opsonized 
Brucella survived as well as, or better than, the opsonized bacteria in the resting LRG-47-/- or 
B6 macrophages. Post-hoc analysis revealed that averaging the opsonized and non-opsonized 
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LRG-47-/- macrophage results together based on IFN-γ activated and non-activated status 
yielded values similar to those recorded from the corresponding IFN-γ treated B6 
macrophage cultures. 
 
Table 2.1. Summary of B. abortus percent intracellular viability results within primary non-
elicited peritoneal macrophages from B6 and LRG-47-/- KO mice. 
 
 
 
 
 
 
 
 
 
Brucella survival in LRG-47-/- unaffected by autophagy inhibitor 
Reduced survival of M. tuberculosis in IFN-γ activated macrophages has been attributed 
to the ability of LRG-47 to redirect resident intracellular bacteria towards lysosomes by 
repackaging intracellular pathogens within autophagosomes (12, 20). The autophagosomal 
pathway could provide a safe haven for the intracellular bacteria enabling them to survive 
and replicate while evading the host immune response, which seems counterintuitive for the 
host. It is plausible that IFN-γ induction of autophagosome biogenesis could either drive the 
elimination of Brucella, or accelerate its survival and intracellular replication. To determine 
which of these mechanisms has the dominant role in Brucella’s intracellular viability, we 
 
Mouse Line Opsonin IFN-γ 48hrs % Survival 
B6 IgG - 114.4 ± 2.7 
B6 None - 123.9 ± 6.9 
B6 IgG + 83.8 ± 13.0 
B6 None + 76.8 ± 15.1 
LRG47 IgG - 79.4 ± 15.01 
LRG47 None - 137.2 ± 12.1 
LRG47 IgG + 95.7 ± 13.2 
LRG47 None + 32.6 ± 0.02 
1 p < 0.01 (C57/B6 vs. LRG47 of same condition) 
2 p < 0.001 (C57/B6 vs. LRG47 of same condition) 
#  p < 0.01 IgG opsonized vs. non-opsonized 
# 
# 
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treated infected peritoneal C57/B6 and LRG47-/- macrophages with 50 µM 3-methyladenine 
(3-MA), a pharmacologic agent known to inhibit autophagosome formation. Within B6 cells, 
the addition of 3-MA reduced Brucella CFUs to 5.8 ± 0.16 log10 for untreated, and 4.6 ± 0.09 
log10.  CFUs equivalent to those recovered from B6 IFN-γ activated cultures with a value of 
4.3 ± 0.56 log10 (Figure 2.4).  Interestingly, the reduced levels of Brucella recovered from 
nonactivated LRG47-/- cells observed earlier remained unchanged by administering 3-MA or 
IFN-γ supplementation. Co-administration of these agents had a synergistic effect that 
significantly decreased the number of intracellular bacteria in both the wild-type (WT) and 
LRG-47 deficient mouse macrophages.   A more dramatic drop in bacterial survival was seen 
within LRG-47 KO macrophages (B6: 3.2 ± 0.06 log10; LRG-47-/-: 0.6 ± 0.8 log10) than in 
wildtype. The relative health of infected macrophages was monitored for gross 
morphological changes by phase microscopy, and enzymatically by 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assays. Incubating cells with 3-MA 
and IFN-γ at the levels tested was found to have no detrimental effect on macrophage health 
(data not shown).  
LRG-47 contributes to stability of chronic Brucellosis in mice. 
To determine the overall contribution of LRG-47 to host resistance during chronic 
brucellosis, the number of B. abortus residing within the spleens of experimentally infected 
B6 and LRG-47-/- mice were followed for 9 weeks post infection.   The LRG-47 mutation 
was introduced into the L129 background for initial experiments (data not shown).  Both 
C57/B6 and L129 F-2 hybrids were used as controls for Brucella infection. Time points at 2 
and 6 weeks post infection showed no significant difference between any of the mouse lines, 
including the controls (data not shown). We determined the chronic brucellosis models in 
C57/B6 and L129 mice were equivalent and subsequent mouse experiments were performed 
in C57/B6 mice.  It is standard that Brucella are routinely recovered from the spleens and 
livers of C57 mice up to and beyond 12 weeks. The splenic colonization study was repeated 
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with C57/B6 and LRG-47-/- mice and no differences in colonization of B. abortus were seen 
between the two models.  Continuing this second study out to 9 weeks post infection revealed 
a significant decrease in the amount of bacteria recovered from the spleens of LRG-47-/- mice 
(Figure 2.5).  A semi-quantitative assessment for the presence of anti-Brucella antibodies 
revealed that sera from LRG-47-/- mice was less able to agglutinate heat killed bacteria, 
suggesting a possible deficiency in the production of anti-Brucella antibodies (data not 
shown).  
Figure 2.4. Brucella survival in LRG47-/- macrophages is unaffected by the autophagy 
inhibitor 3-methyladenine (3-MA). Peritoneal macrophages were collected from C57/B6 and 
LRG-47-/- mice and infected with Ig-opsonized virulent B. abortus. Cells were stimulated 
with IFN-γ and treated with 50 μM 3-MA. Colony forming units were enumerated at 1hr and 
48 hrs post infection. Loss of LRG-47 in non- activated cells had a similar effect as treatment 
with 3-MA or IFN-γ in B6 cells on Brucella survival after 48 hrs. The inhibition of 
autophagy plus IFN-γ activation greatly decreased the number of viable Brucella after 48 hrs 
in LRG-47-/- cells. 
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Figure 2.5. Murine model of chronic brucellosis.  Transgenic LRG-47 -/- mice and C57/B6 
mice were infected intraperitoneally with 1X105 CFU of B. abortus 2308. Values represent 
the mean and standard deviation of CFU’s enumerated from a minimum of 5 mice per group 
(** p ≤ 0.01). Separate experiments that included 129/B6 F2 mice yielded similar results of 
no defect spleen colonization before 4 weeks post infection for any group tested, including 
LRG-47 KO mice. 
 
Discussion 
Pro-inflammatory cytokines elicit anti-microbial responses in monocytes and 
macrophages that serve as a critical defense against intracellular pathogens.  Recently, 
attention has been focused on the ability of IFN-γ to stimulate monocytes to alter normal 
intracellular vesicle and organelle trafficking to regain control over intracellular pathogens.  
Many p47 GTPases induced by IFN-γ localize to specific intracellular compartments or 
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structures, and most have been shown to play a role in limiting intracellular parasitism by 
bacterial or protozoan pathogens.  Discovery of the different defense systems of individual 
intracellular niches led to the idea that each of these proteins may patrol a different 
intracellular region within the cell thus providing defense against a variety of intracellular 
pathogens.  For Brucella, production of ROI and NO was found to play a relatively minor 
role in the potent antimicrobial response induced by IFN-γ stimulation in macrophages. The 
most significant effect of IFN-γ activation is the dramatic inhibition of Brucella replication 
that is found to occur between 24 and 48 hrs in non-activated monocytes. Given that IFN-γ 
production by the host is critically important to restriction of Brucella replication in the host, 
we examined the ability of one of the IFN-γ inducible proteins, LRG-47, to inhibit Brucella’s 
ability to replicate intracellularly. 
Peritoneal macrophages collected from LRG-47-/- mice were infected with opsonized 
Brucella with and without IFN-γ stimulation.  We observed a significant reduction in the 
number of bacteria present at 24 and 48 hrs post infection in the LRG-47-/- cells without 
stimulation.  This suggests a requirement for LRG-47 for Brucella survival in the early stages 
after entry into the host cell. To determine the intacellular localization of LRG-47 in regards 
to Brucella, RAW264.7 murine macrophages with and without IFN-γ stimulation were 
infected with opsonized Brucella and stained for LRG-47. We observed a clear 
colocalization of individual Brucella with LRG-47 inside stimulated cells. Within 
RAW264.7 cells expressing the Flag-tagged LRG-47 protein, the overexpressed LRG-47 
colocalized with Brucella phagosomes in an identical pattern to native LRG-47 using IFN-γ 
activated primary and RAW264.7 macrophages. Intracellular replication of bacteria in these 
cells was only inhibited when monocytes were stimulated with IFN-γ.  
Over expression experiments demonstrate that LRG-47 alone is not sufficient to fully 
support intracellular replication of these bacteria. It is likely that additional cellular factors 
stimulated by IFN-γ are needed to inhibit Brucella replication; however, these data show that 
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LRG-47 is, in fact, required by Brucella for replication and/or survival inside a host 
macrophage. 
Intracellular viability of Brucella requires the biogenesis of autophagosomes for 
replication and/or survival.  A plausible explanation is that Brucella must orchestrate 
autophagosome biogenesis to maintain an intracellular niche. Bacterial control over 
autophagosome formation becomes even more critical when anti-Brucella activity in 
macrophages is increased by IFN-γ activation. Loss of LRG-47 was similar in effectiveness 
to 3-MA in inhibiting Brucella replication in nonstimulated macrophages, suggesting a 
similar means of interference in Brucella pathogenesis for both LRG-47 and 3-MA.  
Moreover, blocking autophagosome formation in LRG-47-/- cells revealed that this host 
protein likely supports Brucella viability when host cells are activated with IFN-γ.  This 
support of bacterial replication is likely in the form of stimulating autophagosome formation. 
It should be noted that Brucella did not survive as well in LRG-47 KO cells grown under non 
stimulating conditions suggesting that Brucella possibly requires not only LRG-47, but also a 
low amount of IFN-γ present in the host cell to effectively replicate and survive. 
Brucella are trafficked into different replicative compartments based on whether they 
were internalized by opsonized or non-opsonized means. Opsonized Brucella replicate in a 
modified late endosome, whereas, non-opsonized bacteria replicate in a vesicle sharing 
markers with the endoplasmic reticulum (22). This difference in bacteria trafficking of 
opsonized versus non-opsonized Brucella translates to a difference in a LRG-47 requirement 
for survival and replication in stimulated and unstimulated RAW264.7 macrophages. We 
observed a significant decrease in the percent survival of opsonized Brucella in non-
stimulated LRG-47 KO cells after 48 hrs of infection, suggesting a requirement for LRG-47 
in the survival and replication of opsonized Brucella in unstimulated macrophages. 
Opsonized Brucella encounter conditions similar to this in the first stages of infection of a 
host before an immune response has been induced.  LRG-47 is required at this stage of 
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infection to provide Brucella with its appropriate trafficking compartment through which it 
will access its replicative late endosome-like vesicle. A low percent of non-opsonized 
Brucella were found to survive after 48 hrs of infection in a stimulated LRG47 KO cell.  This 
data suggests that LRG-47 plays a protective role for non-opsonized Brucella in an IFN-γ 
stimulated cell.  LRG-47 may ‘rescue’ the non-opsonized Brucella and provide it with a 
niche protecting it from anti-bacterial actions of the cell that occur during IFN-γ activation.  
It is clear by in vitro experiments that LRG-47 supports replication of Ig-opsonized 
Brucella in non-activated cells and the survival of non-opsonized Brucella in IFN-γ activated 
cells. By performing in vivo experiments with an LRG-47-/- mouse we were able to confirm 
the significant role LRG-47 has in Brucella pathogenesis. A significant decrease in viable 
Brucella was recovered from the spleen of LRG-47-/- mice after 9 weeks of infection 
confirming a requirement for LRG-47 in Brucella survival and replication inside the host.  
Survival of Brucella within monocytes is the single most important aspect of 
pathogenesis contributing to persistence of the bacteria in host tissues.  The previous in vitro 
data suggests that the role LRG-47 plays during Brucella infection is conditional based on 
IFN-γ stimulation and the opsonization status of the bacteria prior to internalization. High 
IFN-γ levels during the chronic phase are attributed to limiting the numbers of Brucella 
within the spleens of infected mice. Anti-Brucella immunoglobulin undergoes rapid class 
switching to high affinity IgG2a in an IFN-γ dependent manner, coincidently, aiding in the 
establishment of the chronic plateau phase of Brucella occurring at 2 weeks post infection. 
Internalization would likely transition from mostly non-opsonized within the first few days 
towards immunoglobulin-opsonization that would last throughout the chronic phase. It is 
difficult to predict which set of conditions would predominate within the host at any 
particular time during infection. Infection of LRG-47 KO mice with B. abortus did not differ 
in the magnitude or timing of splenic colonization compared to B6 mice. Considering that 
IFN-γ levels and antibody production increase over this time span, the stable number of 
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Brucella detected in vivo during the chronic phase is likely the product of mixed populations 
of variably opsonized bacteria together with fluctuating IFN-γ activation of host monocytes. 
In fact, recalculating percent survival of Brucella in LRG-47 cells (Table 2.1) by averaging 
the opsonized and non-opsonized values together for IFN-γ treated and non-treated equal the 
percent survival of Brucella recovered from similarly treated B6 macrophages.  
Past research regarding LRG-47’s affect on pathogenic infection has determined a 
requirement for LRG-47 to reduce the replicative capacity of infectious agents such as T. 
gondii, Mycobacterium tuberculosis (17), and L. monocytogenes (15).  B. abortus is unique 
from other intracellular pathogens in that LRG-47 does not inhibit its survival and 
replication, but aids it. LRG-47 and other members of the p47 GTPase family are pathogen 
specific with the ability to decipher between two pathogens that share >99% of their open 
reading frames as in C. trachomatis and C. muridarum with C. trachomatis infection being 
kept at bay by LRG-47 but not C. muridarum (18). In the future it will be important to 
perform similar experiments using B. melitensis to determine the role of LRG-47 in this 
related subtype’s ability to survive and replicate inside the host. Similarly, trafficking, 
survival, and replication experiments with Ig-opsonized and non-opsonized B. melitensis in 
IFN-γ activated and non-activated cells will be important to report any differences in 
behavior of this closely related subtype. Though the mouse has proven to be a good model 
for Brucella infection, it is important to look further into the impact of LRG-47 on B. abortus 
infection in human monocytes in the future. 
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Figure S2.1. Internalization and intracellular viability of IgG opsonized and non-opsonized B. 
abortus. Monolayers of Raw264.7 cells were infected with increasing concentrations of IgG-
opsonized or non-opsonized B. abortus. The average CFU per time point illustrates the 
correlation between the amount of Brucella internalized following infection, and the rate of 
Brucella replication and survival. To compare results from opsonized and non-opsonized 
Brucella, remaining experiments were normalized to numbers of Brucella taken up by cells 
using MOI’s of 20:1 for ops and 100:1 for non-ops.  Results represent means ± standard 
deviation of samples in triplicate, and were confirmed by separate independent experiments.  
T=0, 0.5 hours post infection, T=1, 24 hours post infection, T=2, 48 hours post infection. 
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Figure S2.2. Effect of IFN-γ treatment on Brucella infected Raw264.7 cells.  Pretreatment of 
Raw264.7 cells with 50 μg/μl of IFN-γ 24 hours prior to infection with B. abortus induces an 
anti-bacterial response that increases Brucella killing at 24 hrs post infection (T=1), 
continuing through 48 hrs post infection (T=2), T=0 represents 0.5 hours post infection. 
Magnitude of anti-Brucella effect was equal among opsonized and non-opsonized Brucella. 
Similarly, bacterial survival at 24 hrs post infection, and replication detected at 48 hrs were 
the same between opsonized and non-opsonized bacteria infected at normalized MOI’s. 
Results represent the means and standard devation from 6 replicate wells for each condition 
and time point. Statistical analysis was performed using non-paired Student’s t-test. 
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Figure S2.3. Effects of opsonization on Brucella survival in LRG-47 knockout peritoneal 
macrophages. Peritoneal macrophages were collected from LRG-47-/- mice and infected with 
Ig-opsonized or non-opsonized virulent Brucella abortus. Colony forming units (CFU) were 
enumerate at 30 minutes, 2 hrs, 24 hrs, and 48 hrs post infection and percent survival was 
calculated compared to CFU/ml 30 minutes post infection. Ig-opsonized Brucella have a 
lower percent survival in the non-activated cells than they do in the activated cells suggesting 
a requirement for LRG-47 in opsonized Brucella survival in non-activated macrophages. In 
IFN-γ stimulated cells the percent survival of the Brucella steadily decreases over the 
duration of 48 hours whereas in the non-activated cells there is a sharp increase in percent 
survival between 24 and 48 hours post infection. 
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Abstract 
Autophagy is a well conserved and highly orchestrated cellular mechanism that degrades 
unwanted cytosolic material, including damaged organelles and aggregated proteins, and 
recycles core molecules and substrates for future use by the cell. Starving cells of amino 
acids or serum increases autophagy activity as does stimulating cells with proinflammatory 
cytokines such as interferon-γ. While examining autophagy specific responses to IFN-γ 
stimulation by monocytes, we observed an accumulation of discreet, extracellular structures 
in spent media that are significantly larger than exosomes (0.2 um avg.) averaging 2 µm in 
size.  These repeatedly observed structures were positive for LC3, LAMP1, Rab7 and V-
ATPase cellular markers frequently found within autophagosomes inside cells. Accumulation 
of the autophagosome-like vesicles in spent culture media was enhanced by stimulating 
autophagy with rapamycin, serum and amino acid starvation. In contrast, extracellular 
accumulation was not reduced in the presence of the pharmacologic inhibitor of autophagy, 
3-methyladenine. The extracellular autophagosome-like structures were readily internalized 
by cells cultured separately by co-incubating with either spent tissue culture media 
containing these extracellular vesicles or with concentrated extracts produced by size 
exclusion columns and centrifugation. Cell to cell transfer and intracellular trafficking of 
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these structures after internalization was visualized by performing live-cell confocal 
microscopy with vesicles produced from RAW264.7 cells transiently transfected with an 
LC3-RFP expression construct in addition to western blot analysis. Cells internalizing these 
structures localized the extracellularly derived vesicle within the homologous membrane 
compartment of an autophagosome. Since we observed that the extracellular vesicles 
harbored cellular content that could be shared between separate cells in culture, we favor 
terming these structures “bariphores”. It is possible that these extracellular organelles may 
serve as antigen delivery vesicles for quick and efficient antigen presentation by cells that 
never encounter pathogen as well as providing a means of antigen preservation within a host.   
 
Introduction 
Macroautophagy, commonly known as autophagy, is a regular occurring process inside 
many cell types.  Autophagy acts as the garbage processing center of the cell, where 
damaged proteins and organelles are broken down so their contents can be reused by the 
cells.  Along with damaged proteins, the autophagy processes are important for degrading 
protein aggregates, influencing cell death, and clearing intracellular pathogens (1, 2).  
Research to describe the autophagy pathway in detail has been performed primarily on the 
yeast Saccharomyces cerevisiae, but the pathway is well conserved in mammalian cells (3).  
The generation of the intracellular double membrane bound vesicle begins with a portion of 
the rough endoplasmic reticulum membrane(4), called the phagophore, extending in length 
via assistance of the autophagy related (Atg) proteins, Atg12 and Atg5 (5).  Class III 
phosphatidylinositol-3-phosphate (PI3P) is also a crucial phospholipid involved in the 
elongation and expansion of the phagophore membrane (6). The Atg12-Atg5 complex is 
responsible for the recruitment of the protein Atg16, and the microtubule-associated protein 
light chain 3 (LC3)/Atg8. Prior to its proteolytic cleavage by Atg4 protease, LC3 is found in 
the cytosol as pro-LC3 (7).  After its proteolytic cleavage, pro-LC3 is converted to the 
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cytosolic form, LC3-I. LC3 is covalently linked to phosphotidylethanolamine (PE) molecules 
after its ubiquitination, converting it from the LC3-I glycosylated form to the active LC3-II 
form (8). The LC3-II bound PE is incorporated into both the exterior and interior sides of the 
phagophore membrane and is responsible for the curvature and eventual sealing of both ends 
of the phagophore membrane (5) forming the early autophagosome.  The Rab GTPase (small 
molecular weight GTP-binding proteins) Rab5, which is present on the early autophagosome 
membrane, is required for trafficking and further development of the autophagosome (6).  
The GTPase Rab7 is recruited to the membrane removing Rab5 and transitioning the vesicle 
into a late autophagosome (9, 10).  Rab7 is required for trafficking of the late autophagosome 
to fuse with the lysosome (6), creating an autolysosome that averages about 1 μm in diameter 
(8).  The presence of many lysosomal proteins is maintained in/on the newly formed 
autolysosome, such as vacuolar H+-ATPase (V-ATPase), cathepsins, acid hydrolases, and the 
lysosome associated membrane protein 1 (LAMP1)(4, 11).  V-ATPases on the membrane 
acidify the autolysosome and the contents are subsequently degraded, followed later by the 
inner and outer membranes (5, 8).  The contents of the autolysosome are released into the 
cytoplasm of the cell, where they are reused in many cellular processes.   
Autophagy can be induced in mammalian cells through serum starvation, or through 
treatment with Rapamycin, an inhibitor of the mammalian protein mTOR (12).  Autophagy 
can also be induced in macrophages via activating cells through treatment with Interferon-γ 
(IFN-γ) (13).  Both IFN-γ and Rapamycin treatment of cells is shown to upregulate the 
ubiquitination of LC3-I to LC3-II (12, 14).  This process is inhibited by treatment of the cells 
with 3-methyladenine (3MA) (14), and wortmannin.  Both 3MA and wortmannin work 
through inhibiting phosphotidylinositol-3’ kinases (PI3K) that are responsible for the 
formation of PI3P.  The final degradative step of autophagy can be inhibited by nanomolar 
concentrations of bafilomycin A1 which inhibits the cellular V-ATPase (15).   
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In RAW264.7 murine macrophages a novel extracellular organelle has been identified in 
these studies that contains many characteristics of the autophagy pathway.  The organelle 
identified in these studies differs from the described autophagy process in the literature, in 
that, these organelles are being released by the cell and taken into neighboring cells to 
complete the autophagy process.  We have observed these autophagosome-like extracellular 
organelles produced by one cell, are taken up by a neighboring cell, suggesting this organelle 
could provide a means for antigen transport between cells, a mechanism for a cell to export 
access proteins that it cannot process and degrade efficiently, or a pathway for intercellular 
trafficking of intracellular pathogens giving them the ability to evade the host immune 
system.  In the current study we isolate and characterize a novel extracellular organelle and 
distinguish it from an autophagosome by its response to pharmacologic agents and by 
western blot and scanning laser confocal microscopy. 
 
Materials and Methods 
Cell culture and transient transfection 
RAW264.7 murine monocytes were passaged every 3 days in DMEM with 10% fetal 
bovine serum (FBS)  and incubated at 37oC/5% CO2. 2.0x106 per reaction of RAW264.7 cells 
were transiently transfected with 2 μg total LC3-GFP and/or Rab7WT-RFP (wild-type form), 
Rab7TN-RFP (dominant negative form), or Rab7QL-RFP (constitutively active form) 
plasmid constructs using Amaxa Nucleofector® kit V for RAW264.7 cells.  Cells were 
allowed to recover after nucleofection for 6 hours prior to autophagosome induction at 
37oC/5% CO2.   
Autophagosome-like vesicle generation, staining, and harvesting 
Autophagy was induced by three different treatments; serum starvation by treatment with 
Opti-MEM, 20 μM Rapamycin, or 200 U/ml recombinant human IFN-γ (Sigma) in Opti-
MEM for 24 hours at 37oC/5% CO2.  Control cells were treated with Opti-MEM 
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supplemented with 10% FBS.  Pharmacologic treatments were given at time of autophagy 
induction for each treatment group at concentrations of 10 mM or 40 mM 3-methyl adenine 
(3MA), 100 nM or 400 nM wortmannin, 25 nM, 50 nM, or 100 nM Bafilomycin A1 and 30 
μM Cytochalasin D for 24 hours at 37oC/5% CO2 while inducing autophagosome generation.  
LysoTracker® DND-99 (Invitrogen) was used at a ratio of 1:500 for 10 minutes at 4oC and 
then the cells were fixed for 10 minutes at -20oC with 100% acetone.  When vesicles were 
not collected for use in a consecutive experiment, cells were centrifuged at 90 x g for 10 
minutes at 25oC and fixed with either 100% acetone or 4% paraformaldehyde depending on 
staining requirements. 
Autophagosome-like vesicle isolation 
RAW264.7 cells were nucleofected with 1.923 μg of siRNA for LC3α/β (sc-156052 
Santa Cruz Biotechnologies, Santa Cruz, CA) as per the Amaxa Nucleofector® kit V 
protocol and transferred to prewarmed DMEM+10% FBS at a final concentration of 5.0 x105 
cells/ml.  Five ml of cells were seeded into tissue culture treated T-25 flasks and incubated 
for 24 hours at 37oC/5% CO2. Control flasks were seeded with RAW264.7 cells that had been 
nucleofected without DNA, added to pre warmed media to a final concentration of 5.0 x 105 
cells/ml, and 5ml of cells were seeded into tissue culture treated T-25 flasks.  After 24 hours, 
the media was removed from the flasks and cell monolayers were washed with phosphate-
buffered saline (PBS) and 5ml of fresh DMEM+10% FBS, Opti-MEM, DMEM+10% 
FBS+20uM Rapamycin, or DMEM+10% FBS+200U/ml IFN-γ containing pharmacologic 
inhibitors such as 10 mM 3MA, 100 nM Wortmannin, or 25 nM Bafilomycin A1was added.  
Flasks were incubated for 24 hours at 37oC/5% CO2.  After 24 hours, supernatants were 
removed from flasks and centrifuged at 90 x g for 10 minutes at 4oC.  Cell monolayers in 
each flask were washed with PBS and incubated for 10 minutes at room temperature in 2X 
sodium dodecyl sulfate (SDS) laemmli sample buffer.  After 10 minutes, whole cell 
monolayer lysates were collected and frozen at -80oC.  After supernatants were centrifuged, 
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post-nuclear supernatants were decanted into an Amicon Ultra-15 ultracentrifugal filter of 
NMWL 100,000 (Millipore, Billerica, MA).  Dead cell pellets remaining in the bottom of the 
centrifuged supernatants were lysed in RIPA lysis Buffer (150mM sodium chloride, 1.0% 
Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate, 50mM Tris, pH 
8.0) for 45 minutes at 4oC and mixed with 6X SDS laemmli sample buffer and 100X protease 
inhibitor cocktail (Thermo Scientific) and frozen at -80oC.  Post-nuclear supernatants were 
centrifuged at 4,000 x g for 60 minutes at 4oC.  After centrifugation, protease inhibitor 
cocktail was added to the concentrated supernatants and the filter run through. A TCA 
precipitation was performed on both the concentrated supernatants and the filter run through.  
A solution of 10% TCA (500g trichloroacetic acid in 227 ml of dH20) was added to the 
filtrates, and incubated on ice for 45 minutes, after which time the samples were centrifuged 
at 10,000 x g for 45 minutes at 4oC.  Supernatants were removed from the pellet, and the 
pellet was resuspended in 1.0 ml of 100% acetone and centrifuged at 10,000 x g for 45 
minutes at 4oC. This was repeated once more, and the protein pellets were dried in a 
vacufuge at 30oC for 5 minutes.  Protein samples were resuspended in 8M urea containing 1x 
protease inhibitor cocktail and A280 was measured using the nanodrop. 
Western blotting 
Protein samples collected directly into laemmli sample buffer were loaded equally by 
volume at 14ul of each sample per well. Whole cell lysate samples were heated for 10 
minutes in 100oC heating block and cooled before loading onto a 12% TGX Tris-glycine gel 
(Biorad, Hercules, CA).  All other protein samples were measured on the nanodrop and 
loaded equally by protein concentration.  Samples collected in Opti-MEM media were loaded 
equally to each other but not equally to those samples containing FBS.  Samples collected 
from media containing FBS were loaded comparably in mg of protein per well.  All protein 
samples were aliquoted for equal mass of protein and mixed with 6X SDS laemmli sample 
buffer and heated to 100oC heating block for 2 minutes.  Samples were centrifuged for 2 
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minutes at 13,000 rpm and loaded into a 12% TGX Tris-glycine gel.  Protein gels were run at 
200V for 45 minutes and transferred to a 0.2 μm nitrocellulose membrane at 100V for 1 hour.  
Membranes were blocked overnight at 4oC in Tween 20 blocking Buffer (2.42 g Tris, 8.0 g 
sodium chloride, 1.0 g gelatin, 1.0 ml Tween-20 in 1 L d H20, pH 7.5). Membranes were 
incubated in 1/200 Rabbit anti-LC3A (Sigma L8793) overnight at 4oC. Membranes were 
washed and incubated in 1/1000 Alkaline Phosphatase-conjugated AffiniPure F(ab’)2  
Fragment Goat Anti-Rabbit IgG (Jackson ImmunoResearch, West Grov, PA) for 1 hour at 
room temperature.  Membranes were washed again and incubated in Fast Red (Sigma, St. 
Louis, MO) chromogenic substrate for 30 minutes at room temperature and air dried. 
Live cell time-lapse imaging 
For live cell imaging and membrane fusion experiments before autophagy induction, 
transiently transfected cells were stained with a general membrane stain PKH26 (Invitrogen, 
Carlesbad, CA) at 10-6 M in 1.0 ml Diluent C for 5 minutes at room temperature after which 
time 1.0 ml 100% FBS was added to the stain solution and incubated for 1 minute at room 
temperature.  Cells were washed 3 times with DMEM+ 10% FBS and treated for autophagy 
induction as stated above.  Autophagosome-like vesicles were harvested by collecting the 
supernatant from the induced cells and kept at 4oC for up to 8 hours post harvest.  RAW264.7 
cells were seeded into a zero-glass bottom 96-well plate at a density of 2.0 x 106 cells per 
well and incubated for 10 minutes at 37oC/5% CO2.  Spent media was removed completely 
and 200 μl of harvested autophagosomes were added to the well.  Three color scanning laser 
confocal microscopy (SLCM) was used to obtain images for separate fluorophore channels 
by strobe emission/collection every 10 seconds to create a movie of autophagosome uptake 
by RAW264.7 cells in real time.  
Autophagosome-like vesicle trafficking and uptake 
For autophagosome-like vesicle trafficking experiments, vesicles were produced and 
harvested as stated previously and coincubated with target cells.  Target cells were seeded in 
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wells 10 minutes prior to coincubation with harvested autophagosome-like vesicles.  At the 
time of target cell seeding, cells were stained with a ratio of 1:1000 Bodipy® FL C5 
(Invitrogen) in Opti-MEM for 2 hours at 37oC/5% CO2.  After incubation with stain, spent 
media was removed and replaced with either Opti-MEM supplemented with 10% FBS, Opti-
MEM, Opti-MEM+20 μM Rapamycin, or Opti-MEM+200 U/ml recombinant human IFN-γ 
(Sigma).  Cells were coincubated with equal volumes of media containing harvested 
bariphores for 24 hours at 37oC/5% CO2.  Blue fluorescent 2.0 μm FluoSpheres® 
carboxylate-modified microspheres (365/415, 2% solids) (Invitrogen) were used as a control 
for cellular uptake experiments.  Beads were opsonized using dog gamma globulin at a ratio 
of 1:500 in Opti-MEM for 30 minutes at room temperature.  Opsonized and non-opsonized 
beads were added to each well containing a monolayer of RAW264.7 cells at a ratio of 
1:1000 and centrifuged immediately at 120 rpm for 10 minutes at 4oC.  Cells were incubated 
with beads for 24 hours at 37oC/5% CO2. 
Immunofluorescence microscopy 
Rat anti-1D4B (anti-LAMP1) (Hybridoma Bank, University of Iowa, Iowa City, IA) used 
at a concentration of 1/25 diluted in BSP (50 ml PBS, 50 mg saponin, 125 mg BSA) +0.5% 
donkey serum for 1 hour at room temperature.  Goat polyclonal IgG anti-Rab7 (Santa Cruz 
Biotechnologies) was used at a ratio of 1:500.  All secondary antibodies were purchased from 
Jackson ImmunoResearch, conjugated with a fluorescent molecule, and used at 
concentrations of 1/250 diluted in BSP and stained for 1 hour at room temperature.  
Coverslips were mounted using ProLong® Gold Antifade reagent with DAPI (Invitrogen).  
Three color laser scanning confocal microscopy (SLCM) was used to obtain images for 
separate fluorophore channels by strobe emission/collection.  Pearson’s coefficients were 
calculated using Olympus Fluoview software ver. 2.1b.  Post acquisition image processing 
was performed with ImageJ v1.33g (http://rsb.info.nih.gov/ij/index.html). 
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Results 
Identification of extracellular vesicles released from RAW264.7 cells 
While characterizing the antimicrobial responses of monocytes, extracellular vesicles 
approximately 2 µm were frequently seen in cell culture supernatants and extracellular space. 
Initially, the origin of the vesicles was attributed to cell disruption during cell culture 
manipulation. Upon closer examination of monocytes cultured in media with variable 
amounts of nutrients, it appeared that cultures grown with nutrient poor media produced 
more extracellular vesicles than cells grown in rich media supplemented with FBS. Given 
that serum starvation is a potent inducer of autophagy (12), we explored the potential link 
between the autophagosomal pathway and the formation of extracellular vesicles.  
RAW264.7 cells were transiently transfected with an LC3-GFP construct to visualize 
autophagosome formation. Transformed cells were sub-cultured in different Opti-MEM 
based media to provoke amino acid starvation, Opti-MEM supplemented with 10% FBS 
(A.A. starve only), Opti-MEM only (A.A. starve + serum starve), Opti-MEM+Rapamycin 
(A.A. starve induction of autophagy), or Opti-MEM+IFN-γ (A.A. starve with pro-
inflammatory cytokine) for 24 hours.  Acidic lysosomes were labeled by incubating cultures 
with LysoTracker® DND-99 (Invitrogen) prior to fixation.  The cells were centrifuged before 
fixing to collect all secreted vesicles onto the monolayer for 10 minutes at 90 x g, 4oC.  Cells 
were stained with rat anti-LAMP1 antibody, mounted and imaged using laser scanning 
confocal microscopy (SLCM).  Extracellular LC3-GFP positive vesicles were seen in all 
treatment groups.  The extracellular LC3 positive vesicles were found to be acidic, and all 
vesicles co-localized with LAMP1 stain (average Pearson’s coefficient of 0.418 ±0.228 and 
0.724 ± 0.146, respectively).   Extracellular LC3 positive vesicles were also observed to be 
internalized by non-LC3-GFP expressing cells in all treatment groups (Figure 3.1a).  The 
extracellular and internalized LC3 positive vesicles were found to be an average of 2.0 μm in 
diameter, and more than one internalized LC3 positive vesicle per cell in all treatment groups 
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was never observed (Figure 3.1a).  Consistent observations were noted over 5 separate 
experiments. This same set of test conditions was duplicated, and cells were stained with goat 
anti-Rab7 antibody.  The Rab7 staining was found to be co-localized with both extracellular 
and internalized vesicles.  Two replicates of this set of experiments were performed, and the 
same results were observed in each replicate. 
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Figure 3.1. RAW264.7 cells transiently transfected with LC3-GFP and/or Rab7WT-RFP 
constructs.  Cells grown in Opti-MEM+ 10% FBS, Opti-MEM only, Opti-MEM+20 μM 
rapamycin, or Opti-MEM+1/1000 IFN-γ to induce autophagy for 24 hours at 37oC/5% CO2.  
Cells were fixed with acetone and stained using anti-LAMP1 antibodies.  A.) Prior to fixing, 
cells were stained with LysoTracker DND-99, fixed, and stained with anti-LAMP1 
antibodies.  Autophagosome-like extracellular organelles (Bariphore) seen extracellularly in 
all treatment groups after 24 hours.  It was observed, in all treatment groups, that the LC3-
GFP expressing bariphores were secreted and taken up by neighboring cells.  These LC3-
GFP expressing bariphores were colocalized with both LAMP1 and LysoTracker stains.  
Arrows indicate LC3+ extracellular autophagosome-like vesicles colocalized with 
LysoTracker DND-99 and LAMP1 that have been internalized by a non-LC3-GFP 
expressing cell. B.)  Cells co-transfected with Rab7WT-RFP and LC3-GFP produced GFP 
fluorescing bariphores that were also RFP labeled.  These LC3-GFP-Rab7WT-RFP labeled 
bariphores colocalized with LAMP1 staining and were secreted as well as taken up by 
neighboring cells. Arrows indicate an LC3+ autophagosome-like extracellular organelle 
colocalized with Rab7 and LAMP1 found extracellularly. 
 
RAW264.7 cells were transiently co-transfected with LC3-GFP and Rab7WT-RFP 
constructs and treated for autophagy induction as stated earlier.  Cells were stained with anti-
LAMP1.   Extracellular LC3-GFP positive vesicles were also expressing the Rab7WT-RFP 
construct.  These dually expressing extracellular vesicles also co-localized with the LAMP1 
stain in all treatment groups.  These experiments were performed a minimum of three times, 
each revealing the same results (Figure 3.1b). 
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LC3 positive autophagosome-like extracellular vesicles can be internalized by 
neighboring cells via actin-independent membrane fusion 
RAW264.7 cells transfected with the LC3-GFP construct and stained with PKH26 
general membrane stain (Invitrogen) were treated with rapamycin to induce autophagy.  
Fluospheres® 2 μm in diameter, were added to supernatants containing LC3-GFP positive 
extracellular vesicles that were harvested and chilled to 4oC.  Supernatants were co-incubated 
with pre-chilled RAW264.7 cells that were pretreated with cytochalasin D; one set of control 
cells was not treated with the inhibitor.  Cells were fixed after 30 minutes of incubation at 
4oC.  A control set of cells with the same treatment was incubated at 37oC for 30 minutes and 
fixed.  Using scanning laser confocal microscopy (SLCM) we observed that LC3+ 
autophagosome-like extracellular vesicles were internalized in all treatment groups both at 4o 
and 37oC.  Fluospheres® in the same samples were not internalized by either the treated or 
the untreated cells at both test temperatures.  Puncta of the PKH26 membrane stain were 
observed on the plasma membrane of target cells that internalized an LC3+ autophagosome-
like extracellular vesicle, while the LC3-GFP fluorescing vesicle was still membrane bound 
inside the target cell (Figure 3.2a).   
LC3 positive extracellular vesicles were generated in the same way as mentioned above, 
and their uptake by live cells was captured by video. Target cells for video were untreated 
and unstained RAW264.7 cells.  In 10 minutes of footage, we observed a PKH26 stained 
LC3-GFP expressing extracellular vesicle fuse with the target cell plasma membrane and was 
slowly internalized by the target cell.  After internalization was complete, the PKH26 stain of 
the extracellular vesicle membrane was integrated into the plasma membrane of the target 
cell, and the contents of the LC3-GFP extracellular vesicle were observed to be membrane 
bound in the cytoplasm of the target cell (Figure3.2b). 
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A.) 
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Figure 3.2.  Autophagosome-like vesicles taken up by actin-independent membrane fusion. 
RAW264.7 cells stained with PKH26 were transiently transfected with and LC3-GFP 
construct and grown in either Opti-MEM+ 10% FBS, Opti-MEM only, Opti-MEM+20 μM 
rapamycin, or Opti-MEM+1/1000 IFN-γ to induce autophagy for 24 hours at 37oC/5% CO2.  
Supernatants were harvested.  A.) Harvested supernatants were cooled to 4oC, combined with 
blue Fluospheres®, and co-incubated with a monolayer of RAW264.7 cells treated with 
cytochalasin D.  Cells were incubated for 30 minutes at 4°C and 37°C, fixed with 4% 
paraformaldehyde, and visualized using scanning laser confocal microscopy.  In all 
temperature and treatment groups, Fluospheres® were not taken in by the macrophages.  In 
all treatment conditions, LC3-GFP and PKH26 fluorescing bariphores were taken up by 
neighboring cells. Arrows indicate polystyrene beads, or LC3+, PKH26 stained 
autophagosome-like vesicles that have been internalized by the target cell after 30 minutes 
incubation.  B.) Harvested bariphores were coincubated with a RAW264.7 cell monolayer 
and a video was captured for 45 minutes.  The first frame of the video (t=0) shows the 
PKH26 stained bariphore that is also LC3-GFP expressing sitting on the surface of the cell.  
After 35 minutes (t=35), it is evident that the PKH26 stained membrane of the bariphore has 
incorporated into the membrane of the RAW264.7 cell, and the LC3-GFP is membrane 
bound and was delivered to the inside of the cell. Arrows indicate PKH26 lipid stain 
incorporating into the membrane of the cell that took up the LC3+ vesicle, while the LC3-
GFP expressing contents are internalized. 
 
Release of LC3 positive autophagosome-like extracellular vesicles not inhibited by 
known autophagy inhibitors 
RAW264.7 cells expressing LC3-GFP were treated for autophagy induction either by: 
Opti-MEM supplemented with 10% FBS, Opti-MEM only, Opti-MEM+Rapamycin, or Opti-
MEM+IFN-γ.  At the same time as induction began, the cells were all treated with 10 mM 
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3MA and incubated for 24 hours.  Cells were stained with LysoTracker DND-99, fixed, and 
stained with anti-LAMP1. The 3MA treatment of the cells inhibited LAMP1 and LC3-GFP 
co-localization within the cells in all treatment groups, as expected (average Pearson’s 
coefficient of 0.596 ± 0.117). Although LAMP1 was found to loosely co-localize with LC3 
inside cells, LC3+ autophagosome-like extracellular vesicle production, acidification, 
secretion and internalization by target cells was not inhibited by treatment with 3MA in all 
test conditions (Figure 3.3).  This set of experiments was repeated treating cells with 40 mM 
3MA, and no change in acidification, production, secretion, or internalization of LC3+ 
autophagosome-like extracellular vesicles was observed.  
A similar set of experiments was performed with LC3-GFP expressing RAW264.7 cells 
induced for autophagy and treated with 100 nM wortmannin.  Cells were stained with 
LysoTracker® DND-99, fixed, and stained for LAMP1 and observed using scanning laser 
confocal microscopy.  We observed that the wortmannin treatment inhibited the co-
localization of LAMP1 and LC3 inside the cells (average Pearson’s coefficient of 0.558 ± 
0.108).  Although autophagy was inhibited in the cells, the wortmannin treatment did not 
inhibit production or release of LC3+ autophagosome-like extracellular vesicles.  The 
extracellular LC3 positive vesicles co-localized with LAMP1 and the LysoTracker® stain.  
This set of experiments was repeated with a higher concentration of wortmannin (400 nM) 
and the same results were observed. 
RAW264.7 cells expressing the LC3-GFP construct were grown in Opti-MEM 
supplemented with 10% FBS, Opti-MEM only, Opti-MEM+ Rapamycin, or Opti-
MEM+IFN-γ and all cells were treated with 30 μM cytochalasin D for 24 hours.  Control 
cells were grown in the four types of growth conditions but were not subject to treatment 
with cytochalasin D.  LC3-GFP was observed in all treatment groups to be haphazardly 
distributed in the cells in a very diffuse pattern compared to the control cells.  This effect was 
most pronounced in those cells treated with IFN-γ.  Despite the inhibition of actin 
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polymerization in the cells, LC3+ autophagosome-like extracellular vesicles were observed 
to be excreted and internalized by cells in all treatment conditions just as was observed in the 
control cells (data not shown).   
 67  
Figure 3.3.  3-methyladenine does not inhibit autophagosome-like vesicle production or 
secretion. RAW264.7 cells were transiently transfected with LC3-GFP and grown in either 
Opti-MEM+10% FBS, Opti-MEM only, Opti-MEM+20 μM rapamycin, or Opti-
MEM+1/1000 IFN-γ to induce autophagy for 24 hours at 37oC/5% CO2.  At time of 
autophagy induction, cells were treated with 10 mM (not shown) and 40 mM 3MA- a known 
autophagy inhibitor.  Before fixing, cells were stained with LysoTracker DND-99, fixed with 
acetone, and stained with anti-LAMP1 antibodies and visualized using scanning laser 
confocal microscopy.  It is apparent that 3MA inhibits autophagy inside the cells but fails to 
inhibit the secretion and uptake of LC3-GFP expressing bariphores in all treatment groups.  
Similar experiments were performed using 100 nM and 400 nM wortamannin. Arrows 
indicate LC3+ autophagosome-like vesicles colocalized with LAMP1 and LysoTracker 
DND-99 internalized by non-LC3-GFP expressing cells. 
 
Inhibiting V-ATPases with bafilomycin A1 does not inhibit acidification of LC3 positive 
autophagosome-like extracellular vesicles 
RAW264.7 cells expressing LC3-GFP were treated with rapamycin, IFN-γ, serum 
starvation, or serum supplemented Opti-MEM to induce autophagy.  Cells in all growth 
media were treated with 25, 50 or 100 nM bafilomycin A1 and incubated for 24 hours.  Cells 
were stained with LysoTracker® DND-99, fixed, and stained with anti-LAMP1.  
Bafilomycin A1 treatment at 50 and 100 nM concentrations successfully inhibited the 
acidification of lysosomes inside cells in all treatment groups.  However, all concentrations 
of bafilomycin A1 used were unsuccessful in inhibiting the acidification of extracellular and 
internalized LC3 positive vesicles (Figure 3.4).  The LC3-GFP expressed in the extracellular 
as well as the internalized autophagosome-like vesicles was co-localized with LAMP1 and 
LysoTracker with an average Pearson’s coefficient of 0.700 ±  0.184 and 0.774 ± 0.092, 
respectively. 
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Figure 3.4.  Bafilomycin A1 does not inhibit acidification of autophagosome-like extracellular 
vesicles. RAW264.7 cells were transiently transfected with a  LC3-GFP construct, and grown 
in Opti-MEM+10% FBS, Opti-MEM only, Opti-MEM+20 μM rapamycin, or Opti-
MEM+1/1000 IFN-γ to induce autophagy for 24 hours at 37oC/5% CO2.  At time of 
autophagy induction, cells were treated with 25, 50, or 100nM bafilomycin A1. Before fixing, 
cells were stained with LysoTracker DND-99, fixed with acetone, and stained with anti-
Vacuolar-ATPase antibody and visualized using SLCM.  At all concentrations, bafilomycin 
A1 inhibited acidification of the RAW264.7 cells but failed to inhibit acidification of the 
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LC3-GFP expressing bariphores occurring both extracellularly and internalized by 
neighboring cells.  In all treatment groups, LysoTracker, LC3-GFP, and V-ATPase stains 
were colocalized both on internalized and extracellular bariphores. Arrows indicate 
extracellular LC3+ autophagosome-like vesicles colocalized with V-ATPase and 
LysoTracker DND-99.  
 
Secretion of LC3 positive autophagosome-like vesicles by RAW264.7 cells is Rab7 
dependent 
RAW264.7 cells co-transfected with LC3-GFP and Rab7DN-RFP constructs were grown 
in different growth media to stimulate autophagy: Opti-MEM supplemented with 10% FBS, 
Opti-MEM only, Opti-MEM+Rapamycin, or Opti-MEM+IFN-γ.  Cells were fixed and 
stained with anti-LAMP1.  Cells expressing Rab7TN-RFP that had been grown in Opti-
MEM+IFN-γ were found to contain large vesicles with LC3 and LAMP1 on their periphery 
(data not shown).  In all other treatment groups, Rab7TN-RFP expressing cells contained 
smaller LC3 positive vesicles that did not co-localize with LAMP1 (average Pearson’s 
coefficient of 0.404 ± 0.102).  Secretion of LC3+ autophagosome-like extracellular vesicles 
was inhibited with the expression of the Rab7TN-RFP construct in all treatment groups. 
LC3 positive autophagosome-like vesicles colocalized with LC3 of target cell 
RAW264.7 cells nucleofected with an LC3-GFP construct as noted above were combined 
with RAW264.7 cells that had been nucleofected with an LC3-RFP construct in the same 
way.  Cells were grown in different growth media to stimulate autophagy: Opti-MEM 
supplemented with 10% FBS, Opti-MEM only, Opti-MEM+Rapamycin, or Opti-MEM+IFN-
γ. After 24 hours, cells were fixed, mounted, and analyzed using SLCM. LC3-GFP+ 
autophagosome-like extracellular vesicles taken up by non-GFP expressing cells were found 
to colocalize with the LC3-RFP+ autophagosome-like vesicles found within the LC3-RFP 
expressing RAW264.7 cells. The same phenomenon was found with LC3-RFP+ 
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autophagosome-like extracellular organelles taken up into LC3-GFP expressing cells. The 
average Pearson’s coefficient for colocalization of the LC3 of the autophagosome-like 
extracellular organelle and the LC3 of the target cell was found to be 0.443 ± 0.282. 
RAW cells expressing the LC3-GFP construct were co-incubated with opsonized and non-
opsonized 2.0 μm and 0.2 μm Fluospheres® (Invitrogen) for 24 hours while inducing 
autophagy via treatment of cells with either: Opti-MEM supplemented with 10% FBS, Opti-
MEM only, Opti-MEM+Rapamycin, or Opti-MEM+IFN-γ.  Non-opsonized spheres of both 
sizes were not found to be internalized by autophagosome-like vesicles inside the cells of all 
treatment groups.   These non-opsonized spheres were only found extracellularly inside 
apoptotic blebs or floating unpackaged in the extracellular fluid.  When internalized, these 
spheres were not packaged inside the cell but were left unaffected.  Like the non-opsonized 
spheres, the opsonized spheres were not found to be packaged inside autophagosome-like 
extracellular vesicles.  When taken into a target cell, the opsonized spheres were colocalized 
with the lysosomal marker LAMP1 (data not shown).   Opsonized spheres were frequently 
observed in small apoptotic blebs that did not contain LC3 but were acidic and colocalized 
with LAMP1 (data not shown).  
Lipidated LC3-II on autophagosome-like extracellular vesicles isolated from 
supernatant of RAW264.7 cells 
To determine the LC3-II content of extracellular vesicles, supernatants were removed 
from RAW264.7 cells grown in media to induce autophagy and were treated with autophagy 
inhibitors. Autophagosome-like extracellular organelles were isolated from the supernatant 
by running the supernatant over a centrifugal size exclusion column allowing particles under 
100,000 kDa to pass through, retaining the vesicles of interest.  A TCA precipitation was 
performed on the concentrated sample off the filter.  Samples were equally loaded among 
like types (see methods) into a 12% SDS-PAGE gel, and a western blot was performed on 
the proteins using an anti-LC3 antibody (Figure 3.5).  Lipidated LC3-II was found in the 
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supernatants of most treatment groups. A large amount of LC3-II was seen in the 
supernatants from RAW264.7 cells treated with autophagy inhibitors.  The most notable 
increase in lipidated LC3-II seen in the supernatants was from the cells treated with 
bafilomycin A1.  These supernatants also contained pro-LC3 which was not seen in any of 
the other treatment groups (Figure 3.5). The cytoplasmic form, LC3-I was seen in the control 
supernatants taken from RAW264.7 cells grown in DMEM+10% FBS+Rapamycin and 
DMEM+10% FBS+IFN-γ as well as in the supernatants taken from cells grown in 
DMEM+10% FBS and Opti-MEM (Figure 3.5). 
Autophagosome-like extracellular vesicle production inhibited by siRNA for LC3α/β 
RAW264.7 cells were nucleofected with siRNA for LC3α/β and incubated for 24 hours, 
after which time they were given fresh media to induce autophagy, either DMEM+10% FBS, 
Opti-MEM, or DMEM+10% FBS+IFN-γ. Cells were also treated with bafilomycin A1. Non-
transfected cells were used as controls as well as non-treated cells. Supernatants were 
harvested and processed as explained above and a TCA precipitation was performed on the 
concentrated vesicles.  Proteins were analyzed by western blot using an anti-LC3 antibody.  
Transfection with siRNA specific for LC3 α/β was able to greatly decrease the release of 
autophagosome-like extracellular vesicles as indicated by a decrease in lipidated LC3-II in 
the supernatants from the siRNA treated RAW264.7 cells in comparison with the 
supernatants from the control cells (Figure 3.6).  Whole cell lysates are shown to confirm 
accuracy as well as success of the siRNA. 
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Figure 3.5. Lipidated LC3 present in supernants collected from RAW264.7 cells induced for 
autophagy. Supernatants were isolated from RAW264.7 cells grown in DMEM+10%FBS, 
Opti-MEM, DMEM+10%FBS+rapamycin, or DMEM+10%FBS+IFN-γ and treated with 
either 10 mM 3MA, 100 nM wortmannin, or 25 nM bafilomycin A1 for 24 hours. 
Supernatants were run over a centrifugal size exclusion column isolating any proteins or 
vesicles larger than 100,000 kDa.  A TCA precipitation was performed on these isolated 
proteins.  Proteins were equally loaded into a 12% Tris-glycine gel (Biorad) with all proteins 
isolated from samples containing FBS loaded at 47.6 mg/well, and all Opti-MEM samples 
loaded at 4.2 mg/well.  Whole cell lysates were loaded at an equal volume of 14 μl/well.  
Samples were transferred to a 0.2 μm nitrocellulose membrane and labeled with an anti-
LC3A antibody (Sigma). Arrows indicate pro-LC3 (~30kDa), cytosolic LC3-I (18kDa), and 
lipidated LC3-II (15kDa). 
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Figure 3.6.  LC3 required for release of autophagosome-like vesicles from RAW264.7 cells. 
Supernatants were isolated from RAW264.7 cells nucleofected with siRNA for LC3α/β 
(Santa Cruz Biotechnologies) and grown in either DMEM+10%FBS, Opti-MEM, or 
DMEM+10%FBS+IFN-γ.  Cells were treated with 25nM bafilomycin A1 for 24 hours.  
Control cells were nucleofected without siRNA and were untreated. Supernatants were run 
over a centrifugal size exclusion column isolating any proteins or vesicles larger than 
100,000 kDa.  A TCA precipitation was performed on the isolated proteins.  Proteins were 
equally loaded into a 12% Tris-glycine gel (Biorad) with all proteins isolated from samples 
containing FBS were loaded at 44.52 mg/well, and all Opti-MEM samples loaded at 1.92 
mg/well.  Whole cell lysates were loaded at an equal volume of 14 μl/well.  Samples were 
transferred to a 0.2 μm nitrocellulose membrane and labeled with an anti-LC3A antibody 
(Sigma). Arrows indicate pro-LC3 (~30kDa), cytosolic LC3-I (18kDa), and lipidated LC3-II 
(15kDa). 1=DMEM+10%FBS, 2= Opti-MEM, 3=DMEM+10%FBS+1/1000 IFN-γ. 
 
Discussion 
The LC3 positive autophagosome-like extracellular organelles are naturally produced by 
RAW264.7 cells during normal growth conditions.  The production and secretion of these 
extracellular organelles is increased during serum starvation and with rapamycin or 
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interferon-γ treatment.  It is unclear whether treatment with rapamycin, serum starvation, or 
IFN-γ increases the frequency of ingestion by neighboring cells or if the relative frequency of 
ingestion of LC3+ autophagosome-like extracellular organelles is simply a result of increased 
secretion causing an increase in the occurrence of a fusion events between a target cell and an 
autophagosome-like vesicle.  Treatment of RAW264.7 cells with wortmannin did not inhibit 
secretion or production of LC3+ autophagosome-like extracellular organelles, despite the 
inhibition of autophagy.  Likewise, treatment of these cells with high concentrations of 3-
methyladenine did not inhibit the production or secretion of LC3+ autophagosome-like 
extracellular organelles in any of the treatment conditions tested, despite the fact that the 
3MA treatment successfully inhibited autophagosome maturation in these cells.  Secretion, 
production and, most importantly, uptake, are not deterred by inhibiting the actions of actin 
inside the cell with cytochalasin D treatment.   It is clear that LC3+ autophagosome-like 
extracellular organelles are taken into neighboring cells (target cells) by membrane fusion in 
less than 30 minutes, as was clearly shown by our live cell LC3+ autophagosome-like 
extracellular vesicle uptake video where the vesicle membrane was fused with the target cell 
membrane releasing the vesicular contents into the cytoplasm of the accepting cell.   
 LC3+ autophagosome-like extracellular organelles contain many autophagy markers 
such as LC3, LAMP1, V-ATPase, and Rab7. They are differentiated from autophagosomes, 
however, by their size and the inability of nanomolar concentrations of bafilomycin A1 to 
inhibit acidification both extracellularly and inside a non-acidic target cell.   
Although it is probable that this novel extracellular organelle is a product of the 
autophagy pathway, the data does not confirm it. To avoid further confusion, we will from 
this point forward refer to the LC3+ autophagosome-like extracellular organelle as a 
“Bariphore”.   
The release of bariphores is dependent on the GTPase Rab7 as the secretion of these 
vesicles is inhibited by transfection of cells with the Rab7TN construct.  It is clear from the 
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results of the western blot of supernatants collected from cells transfected with siRNA for 
LC3, that LC3 is also essential for release of the bariphore into the extracellular environment.  
As we can see by the blot, little to no bariphores are seen extracellularly in the supernatants 
collected from siRNA transfected cells (Figure 3.6).  
From the information that has been gathered thus far, it is proposed that this organelle 
may be secreted from the cell at the time of late autophagosome fusion with the lysosome but 
before the degradative process begins.  It is unclear what proton pump these extracellular 
organelles have on their surface that allows them to maintain acidity in the extracellular 
environment or inside a non-acidic target cell, as well as the origin of the acidifying agent.  
We are confident that these extracellular organelles are not exosomes or multivesicular 
bodies.  It was shown by Fader et.al. that multivesicular bodies are directed to the autophagic 
pathway and exosome secretion is inhibited under conditions that stimulate autophagy (16).  
The average size of an exosome is about 100-300 nm (17), which is also relatively small 
compared to our bariphores which are an average of 2 μm in diameter.  Although it was 
found that bafilomycin A1 treatment of the mouse epithelial cell line AtT-20 generated mixed 
organelles that shared many markers with autophagosomes, it was never shown that these 
mixed organelles were secreted from the cells.  We are confident that the extracellular 
organelle that we have identified is not the same as the mixed organelle identified by Sobota 
et.al. (15) because our bariphores are appearing in all treatment groups including those that 
are serum starved or treated with rapamycin or IFN-γ.  Most importantly, bariphore secretion 
and internalization occurs in control cells grown in Opti-MEM supplemented with serum.   
At this time it is unknown whether there are other cell types that are able to produce and 
secrete these extracellular organelles. Bariphore production, secretion, and uptake by 
neighboring cells may be critical in long term antigen persistence in the host.   The 
production and secretion of bariphores by macrophages, in general, may play an important 
role in antigen transport to neighboring cells providing a more efficient and rapid display of 
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antigen by cells that have never encountered the pathogen. By this mechanism, the bariphore 
is allowing the first cell that phagocytoses the pathogen to export pathogen antigens for MHC 
class II loading to a variety of different cells throughout the body in a very rapid manner. 
The bariphore may also function as a way for cells to export proteins that they may not 
have the ability or the capacity to efficiently dispose of.  This hypothesis comes from the 
observation of the pro-LC3 found in bariphores isolated from the supernatants of the 
bafilomycin A1 treated cells.  Treating the cells with bafilomycin A1 inhibits degradation of 
unwanted proteins in the cell which allows for these proteins to build up.  The RAW264.7 
cells may be using the bariphores as a way to export unwanted proteins, which they may not 
need at the time.  Other cells may take up this exported waste if they are in need of amino 
acids or other resources which may be found within these exported bariphores. This may 
explain why the bariphores are trafficked into the autophagy pathway of the target cell once 
they are taken up. 
 Though opsonized and non opsonized beads of two different sizes were not found to be 
inside bariphores in any of the treatment groups, it is possible that intracellular pathogens 
such as Mycobacterium tuberculosis, Legionella pneumophila, Coxiella brunetii, Francisella 
tularensis, or Brucella spp. may be able to manipulate the bariphore formation pathway 
enabling them to be packaged into a bariphore.   It is also a possibility that bariphore 
trafficking between different host cell types may be used by a variety of intracellular 
pathogens to infect large numbers of host cells while evading a response by the host immune 
system. This would provide the pathogen the ability to persist inside the host where the 
bariphore could protect them from antibiotics, complement proteins, or antibodies. 
 
Conclusion 
Autophagy is a naturally occurring process inside all host cells as a way to degrade 
unwanted proteins and organelles, as well as pathogens.  The formation of the phagosome 
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membrane is dependent upon many autophagy related proteins (Atg) as well as PI3P and Rab 
GTPases (5). Autophagy can be induced by serum starvation  as well as treatment with 
rapamycin (12) and IFN-γ (13). There are a number of pharmacologic agents known to 
inhibit autophagy such as 3-methyladanine, wortmannin, and bafilomycin A1.  Bariphores 
were found to be excreted by RAW264.7 when grown in conditions to induce autophagy.  
These acidic extracellular vesicles carry a number of autophagosomal markers such as Rab7, 
LC3, LAMP1, and V-ATPase and their release from the cell is LC3 and Rab7 dependent.  
The release of bariphores from RAW264.7 cells cannot be inhibited treatment with 3MA, 
wortmannin, or bafilomycin A1.  The uptake of these vesicles is not actin dependent and 
occurs rapidly through a membrane fusion event. Once taken into a target cell, the bariphore 
is trafficked with the LC3+ bariphores inside the cell that has taken it up as if it was part of 
that cell.  This naturally occurring process may serve as antigen delivery vesicles for quick 
and efficient antigen presentation by cells that has never encountered the pathogen as well as 
providing a means of antigen preservation within a host.   Extracellular release of bariphores 
may also be used by the cell as a way to dispose of unwanted proteins and waste, while other 
cells may take up bariphores as a way to acquire much needed amino acids and nutrients. 
Bariphore trafficking between host cell types may also serve as a means for intracellular 
pathogens to infect large numbers of host cells while evading the host immune system. 
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Abstract 
Brucella species are facultative intracellular pathogens that are able to cause severe 
disease in animals and humans. Brucella are internalized and trafficked differently inside the 
macrophage based on whether the bacterium was opsonized or non-opsonized with serum 
immunoglobulin.  Once internalized, Brucella traffic through the early and late endosome 
where opsonized Brucella will replicate.  Non-opsonized Brucella replicate in a vesicle 
derived from the endoplasmic reticulum.  Autophagy is a process in the cell whereby 
damaged proteins and organelles are broken down so their contents can be reused. Recently, 
an autophagosome like extracellular organelle has been identified that is released by 
RAW264.7 murine macrophages in normal growth conditions and in conditions to induce 
autophagy. We have observed Brucella abortus using the natural intercellular trafficking 
pathway of the autophagosome-like extracellular organelle to infect a new host cell while 
evading the host immune system. 
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Introduction 
Brucella is a gram negative, non-spore forming, coccobacillus capable of living in 
microaerophilic environments (1). The species Brucella contains many sub-species which 
include Brucella abortus (2), Brucella melitensis (2), Brucella suis, Brucella ovis (3), 
Brucella canis (4), Brucella neotomae (5), Brucella ceti (6, 7), Brucella pinnipedialis (6, 7), 
and the latest addition, Brucella microti (1).  Each of these species is host specific with B. 
abortus infecting cattle, B. canis infecting dogs, and B. suis infecting swine (8). Brucella 
abortus is the primary cause of brucellosis in cattle, bison, and elk all over the world (1). 
Brucellosis primarily causes abortions in pregnant cattle (9)  or the birth of weak cows with a 
lower milk output (1). In humans, B. abortus infections result in undulant fever (10) and 
endocarditis (11). 
Brucella is a facultative intracellular pathogen found primarily in the macrophage of its 
host (10). Brucella is internalized by a different mechanism depending on whether the 
surface of the bacterium is opsonized by serum antibodies against Brucella LPS or non-
opsonized. Opsonized Brucella are internalized by Fc receptors on the surface of the 
macrophage, which bind the constant region of the antibody bound to the surface of the 
bacterium (12). Non-opsonized Brucella are bound by the long O-chain of their LPS to lipid 
rafts found occasionally on the surface of the macrophage (13). Within 10 minutes, the 
internalized Brucella, whether opsonized or non-opsonized, is found within a compartment 
that shares many markers of an early endosome (14) such as the early endosomal antigen 1 
(EEA1), the small GTPase Rab5 and the transferrin receptor (12). Along with these early 
endosome markers, this B. abortus-containing compartment is also highly acidic, which is 
thought to be due to the large amount of vacuolar H+-ATPase this compartment carries on its 
surface (15). Once a high acidity is reach in the Brucella-containing compartment, the early 
endosomal markers are lost from the vesicle and late endosomal markers LAMP1 and 
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cathepsin D (16) as is the small GTPase Rab7 and its effector Rab-interacting lysosomal 
protein (RILP) (17). At this stage, 60% of the bacteria are degraded (18). One hour post 
infection, the Brucella-containing compartment interacts with the endoplasmic reticulum 
subdomains of the early secretory pathway called ER exit sites at which point LAMP1 is lost 
from the vacuole surface (19). The pH of the Brucella-containing compartment increases to 
become more permissive to Brucella replication as a pH above 5.5-6 is required for this to 
occur (20). Between 10-12 hours post infection, B. abortus finally begin to replicate in their 
endoplasmic reticulum-like replicative niche (21). The Brucella will replicate in this cell 
until space is no longer available, or nutrients become depleted, at which time they will lyse 
the cell and infect a new cell by an unknown mechanism (20). 
Interferon gamma is essential for resistance to facultative intracellular bacterial pathogens 
(22). It has been shown to be critical for the control of B. abortus infection in vivo and in 
vitro (1).  
Macroautophagy, more commonly known as autophagy, is a regular occurring process 
inside many cell types where damaged proteins and organelles are broken down so their 
contents can be reused by the cells.  Along with damaged proteins, the autophagy processes 
are important for degrading protein aggregates, influencing cell death (23), and clearing 
intracellular pathogens (24, 25).  The autophagosome membrane begins as the phagophore 
and is believed to bleb off from the golgi apparatus (26), the outer nuclear membrane (27), 
the outer mitochondrial membrane (28), or from the endoplasmic reticulum (29). The 
phagophore membrane extends in length via assistance of the autophagy related (Atg) 
proteins, Atg12, which is ubiquitin-like, and Atg5 (30).  Atg12 and Atg5 are attached to each 
other by complexing with Atg 10 and Atg 7 (31). The Atg12-Atg5 complex is responsible for 
the recruitment of the protein Atg16, and the microtubule-associated protein light chain 3 
(LC3)/Atg8 (32). LC3 is covalently linked to phosphotidylethanolamine (PE) molecules after 
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its ubiquitination from the LC3-I glycosylated form to the active LC3-II form (33). The LC3-
II bound PE is incorporated into both the exterior and interior sides of the phagophore 
membrane and is responsible for the curvature and eventual sealing of both ends of the 
phagophore membrane (30) forming the early autophagosome.  The Rab GTPase (small 
molecular weight GTP-binding proteins) Rab5, which is present on the early autophagosome 
membrane, is required for trafficking and further development of the autophagosome (34).  
The GTPase Rab7 is recruited to the membrane, removing Rab5, transitioning the vesicle 
into a late autophagosome (35, 36).  Rab7 is required for trafficking of the late 
autophagosome to fuse with the lysosome (34), creating an autolysosome that averages about 
1 μm in diameter (33).  The presence of many  lysosomal proteins is maintained in/on the 
newly formed autolysosome, such as vacuolar H+-ATPase (V-ATPase), cathepsins, acid 
hydrolases, and the lysosome associated membrane protein 1 (LAMP1) (37, 38).  V-ATPases 
on the membrane acidify the autolysosome and the contents are subsequently degraded, 
followed later by the inner and outer membranes (30, 33).  The contents of the autolysosome 
are released into the cytoplasm of the cell, where they are reused in many cellular processes.   
Recently an autophagosome like extracellular organelle has been found that is released by 
the murine macrophage cell line, RAW264.7 in normal growth conditions and under 
conditions that induce autophagy (Ritchie et al., unpublished data). This extracellular 
organelle, termed a ‘bariphore’, shares many characteristics of an autophagosome such as 
colocalization with LAMP1, the GTPase Rab7, V-H+-ATPase, as well as colocalizing with 
the acidotropic stain LysoTracker® (Ritchie et al., unpublished data). These bariphores are 
taken up into neighboring cells and trafficked into the target cell’s preexisting autophagy 
pathway (Ritchie et al., unpublished data). Previously we showed that LC3 is required for the 
release of the bariphores into the extracellular milieu (Ritchie et al., unpublished data). 
Though the bariphore shares many characteristics with the autophagosomal pathway, its 
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production and release is not inhibited by 3-methyladenine, wortmannin, cytochalasin D, or 
bafilomycin A1, all common inhibitors of autophagy (Ritchie et al., unpublished data).   
We hypothesize that B. abortus within bariphores would be able to infect new cells 
without exposing the bacteria to antimicrobial molecules present in the serum or standard, 
soluble administered antibiotics. Evidence for bariphore mediated transmission of B. abortus 
would demonstrate an effective means for persistent infection to be maintained despite 
antimicrobial intervention and rapid development of anti-Brucella immunoglobulin. Using 
fluorescence confocal microscopy, live B. abortus were readily observed within extracellular 
bariphores. Transfer of culture supernatants containing B. abortus laden bariphores to 
uninfected monocyte monolayers efficiently transmitted the disease to the new monolayer. 
Infection of the monolayer was not reduced or inhibited by the presence of bactericidal 
concentrations of soluble gentimicin. We propose that bariphore mediated transmission of 
Brucella is a significant contributor to Brucella persistence. 
 
Materials and Methods 
Bacteria culture 
Virulent B. abortus laboratory strain 2308 cultures were grown on Trypticase Soy agar 
(Difco) supplemented with 5% bovine blood (BA) (Gemini Bioproducts) under 5% CO2 at 
37oC.  A GFP-expressing derivative of B. abortus 2308 was constructed in prior studies (16) 
by introducing the plasmid pBBR1MCS6-Y encoding GFP expression downstream of the 
constitutively active promoter for aph3A-derived from pBlueKS+Kan (Stratagene) (39). GFP 
positive Brucella were maintained in culture using a concentration of 6 µg/ml 
chloramphenicol. All chemicals were obtained from Sigma-Aldrich unless otherwise stated. 
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Cell culture and transient transfection 
The murine monocytic cell line RAW264.7 (ATCC # TIB-71) murine monocytes were 
passaged every 3 days in DMEM with 10% fetal bovine serum (FBS) and incubated at 37oC 
under 5% CO2. RAW264.7 cells from a fresh split were seeded into 24 well plates, 0.5 
ml/well, each well contained an acid washed circular coverslip. After 24 hours, media was 
removed from all cells, and cells were washed gently with PBS and given fresh prewarmed 
media with or without 200 U/ml recombinant interferon gamma (IFN-γ). Cells were 
transiently transfected by packaging 1 μg of an LC3-RFP construct in lipofectamine 2000 
(Invitrogen) as per the product protocol. Cells were returned to incubator for 24 hours at 
37oC/5% CO2.  
Intracellular viability of B. abortus 
Cell culture monolayers were infected with IgG opsonized B. abortus 2308 harboring the 
GFP encoding plasmid pBBR1MCS6Y as described (16). Supernatants were collected from 
cells infected as explained above that had incubated for 48 hours with bacteria. Supernatants 
from identical experimental groups were combined and used to infect monolayers of 
RAW264.7 cells that had been seeded into a 24 well plate with coverslips at 5.0 x105/ml 24 
hours previously in DMEM+10% FBS. After addition of the supernatants to each well, 500 
μl/well, plates were centrifuged at 90 x g at 4oC for 10 minutes to bring vesicles from the 
supernatant down to the RAW264.7 cell monolayer. Cells were co-incubated with 
supernantants for 2 hours at 37º C / 5% CO2. After 2 hours, media was washed off cells with 
PBS, and cells were given fresh DMEM+10% FBS+10 μg/ml gentamicin and returned to the 
incubator at 37º C / 5% CO2.  Coverslips were fixed 72 hours post infection with the bacteria 
laden supernatants and stained for examination by microscopy.  
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Immunofluorescence microscopy 
Coverslips harboring the adherent and infected macrophages were fixed with freshly 
prepared 4% paraformaldehyde in PBS (pH 7.4) at room temperature for 20 minutes. 
Monolayers were routinely permeabilized with 0.25% bovine serum albumin/PBS solution 
containing a final concentration of 0.1% saponin (BSP). Incubations with primary and 
secondary antibodies were at room temperature on a shaking platform for 1 hour. Primary 
antibody was diluted in BSP and incubated with fixed Brucella infected cells at 1/25 mouse 
anti-LAMP 1 monoclonal (ID4B- Iowa Hybridoma). Secondary antibodies was diluted in 
BSP and used at 1/500 Cy®5-conjugated AffiniPure F(ab’)2 Fragment Rabbit Anti-Mouse 
IgG (Jackson ImmunoResearch). Confocal microscopy was performed with an Olympus 
FV1000 Fluoview laser scanning microscope equipped with 405, 488, 563 and 635 laser 
lines and 4 PMTs. Post-acquisition image processing was performed with ImageJ v1.43m 
(http://rsb.info.nih.gov/ij/index.html). 
 
Results 
Brucella in LC3+, LAMP1+ vesicles inside cells 
To determine if Brucella may be associated with the trafficking pathway of a bariphore 
we infected RAW264.7 murine macrophages transfected with an LC3-RFP construct with 
virulent Brucella abortus that had either been opsonized with serum immunoglobulin (Ig) or 
non-opsonized. Infected cells were activated with IFN-γ or non-activated 24 hours prior to 
infection. Samples were fixed 48 hours post infection and scanning laser confocal 
microscopy was performed after staining for LAMP1. Ig-opsonized Brucella was observed in 
LC3 positive vesicles that colocalized with LAMP1 in non-activated cells. Non-opsonized 
Brucella from IFN-γ activated cells were seen directly adjacent to LC3 positive vesicles but 
were not found to occupy the same space (Figure 4.1). In the non-activated cells, non-
opsonized Brucella were in LAMP1 positive vesicles but were not found in close proximity 
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to LC3 positive vesicles (data not shown).  The same was true for the opsonized Brucella in 
IFN-γ activated macrophages (data not shown). 
 
 
 
Figure 4.1. Brucella are found in LC3 positive and LAMP1 positive vesicles inside 
RAW264.7 cells. Opsonized Brucella in non-activated macrophages colocalize with LC3 
positive vesicles and non-opsonized Brucella from IFN-γ activated cells are tightly adjacent 
to LC3 positive vesicles. RAW264.7 cells transfected with an LC3-RFP construct were 
activated with IFN-γ, or non-activated, and were infected with Ig-opsonized or non-
opsonized B. abortus for 48 hours. Samples were fixed, stained for LAMP1, and images were 
taken using scanning laser confocal microscopy. Non-opsonized Brucella in non-activated 
cells were not found to be associated with LC3 vesicles as was true for opsonized Brucella in 
the IFN-γ activated cells. Though each treatment group of bacteria and macrophage 
activation state interacted differently with LC3 positive vesicles, all Brucella were found in 
LAMP1 positive vesicles. Arrowheads indicate individual Brucella. Bar=5μm. 
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Brucella traffics to a new cells monolayer via bariphores 
In order to determine if Brucella is able to enter into the bariphore trafficking pathway 
and use this pathway to infect a new monolayer of cells, we collected supernatants from an 
infected monolayer and used them to infect new cells.  RAW264.7 macrophages transfected 
with an LC3-RFP construct were activated with IFN-γ or non-activated, and infected with Ig-
opsonized or non-opsonized virulent B. abortus for 48 hours.  After 48 hours, supernatants of 
like types (opsonized +IFN-γ, opsonized without IFN-γ, non-opsonized +IFN-γ, non-ops 
without IFN-γ) were collected and used to infect a fresh monolayer of non-activated 
RAW264.7 cells. After 72 hours of infection, coverslips were fixed and stained for LAMP1 
and analyzed using scanning laser confocal microscopy. Opsonized Brucella were observed 
in LC3 positive vesicles heavily surrounded by LAMP1 in IFN-γ stimulated cells (Figure 
4.2). This same phenomenon was observed for all other treatment groups; opsonized Brucella 
from non-activated cells, and non-opsonized Brucella from both activated and non-activated 
cells (data not shown). 
 
Figure 4.2. Brucella traffic in bariphores to infect new monolayer of macrophages.  
Supernatants were collected from RAW264.7 cells non-activated or treated with IFN-γ, 
transfected with LC3-RFP, and infected for 48 hours with opsonized or non-opsonized 
virulent B. abortus. Supernatants were treated with gentamycin and used to infect a new non-
activated, untransfected monolayer of RAW264.7 cells. Cells were incubated with bacteria-
laden supernatants for 96 hours, fixed, and stained for LAMP1. Scanning laser confocal 
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microscopy was used to collect these images. Arrowheads indicate individual B. abortus 
inside LC3 positive, LAMP1 positive bariphores that have been taken in to a RAW264.7 cell. 
Bar=5μm. 
 
 
Discussion 
Ig-opsonized and non-opsonized Brucella are internalized into macrophages by different 
mechanisms and as a result are trafficked differently once they get into the cell.  Once 
internalized, Brucella pass through the early and late endosome. Opsonized Brucella 
replicate in a late endosome-like compartment, whereas, non-opsonized Brucella replicate in 
a vesicle of endoplasmic reticulum origin.  It has previously been shown in our lab that there 
are mechanistic differences in trafficking between opsonized and non-opsonized B. abortus 
in activated versus non activated murine macrophages (Ritchie et al., unpublished data). 
After 48 hours of infection of IFN-γ activated or non-activated RAW264.7 murine 
macrophages with virulent B. abortus 2308, we observed a colocalization of opsonized 
Brucella with LC3+ vesicles in non-activated cells. Vesicles containing non-opsonized B. 
abortus in activated cells were found closely adjacent to LC3+ vesicles appearing as if the 
two vesicles were docked but the contents had not mixed.  Both opsonized and non-
opsonized bacteria were in LAMP1+ vesicles. Supernatants were isolated from B. abortus 
infected LC3-RFP transfected cells and used to infect fresh monolayers of RAW264.7 cells. 
After 72 hours of infection, opsonized and non-opsonized Brucella in both activated and non-
activated cells were observed in LC3+ vesicles heavily surrounded by LAMP1 inside the 
infected RAW264.7 cell. The origin of the LC3 in these vesicles could have only come from 
the cells originally transfected with the LC3-RFP construct, the cell monolayer originally 
infected. The LC3+, LAMP1+ vesicles containing B. abortus are believed to be bariphores 
originally described in our lab as they share many characteristics. Brucella is able to invade 
this regularly occurring mechanism of bariphore production and release inside the 
 90  
macrophage and use it to transport itself to a new host cell.  We have shown that the 
bariphore protects Brucella from gentamycin treatment, suggesting that this vesicle can 
provide the bacterium protection from innate immune mechanisms such as complement and 
antibody opsonization. This mechanism may provide an explanation for the previously 
unknown mechanism by which Brucella is able to evade the host immune system allowing 
the infection to persist. Knowing that Brucella is able to use the bariphore to traffic to new 
host cells provides insight for a possible persistence mechanism for other intracellular 
pathogens also associated with the autophagy pathway. With this knowledge we can now 
work to develop new drug targets inhibiting the production or release of the bariphore 
whereby inhibiting the persistence of Brucella infection. 
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CHAPTER 5. GENERAL CONCLUSIONS 
General Discussion 
Brucella spp. are intracellular pathogens that survive and replicate inside a late 
autolysosome-like intracellular vesicle if they are opsonized, and an endoplasmic reticulum 
generated vesicle if they are non-opsonized. These studies have shown that Brucella spp. 
require LRG-47 for their replication and intracellular survival inside a macrophage.  LRG-47 
is a p47 GTPase whose activities are induced by the cytokine IFN-γ (1). LRG-47 is important 
in controlling many intracellular pathogen infections such as Mycobacterium tuberculosis 
(2), Salmonella typhimurium (3), Toxoplasma gondii (4), and Trypanosoma cruzi (5). It has 
never before been shown that a pathogen requires the presence of LRG-47 for its survival, as 
has been shown with Brucella abortus. LRG-47 colocalizes to the autophagosome membrane 
and stays on the membrane for the lifespan of the vesicle. Due to LRG-47’s colocalization at 
the membrane of the autophagosome, this p47 GTPase has the ability to control vesicular 
transport inside the cell (3).  It was thought that it was through LRG-47’s control of vesicular 
transport that the cell was able to control pathogenic intracellular infection (3).  In previous 
studies, there was no significant difference seen in viable Brucella recovered from C57/B6 
mice and LRG-47 knockout mice treated with the autophagy inhibitor, 3-methyladenine 
(3MA). 3MA is a phosphotidylinositol-3’ kinase (PI3K) inhibitor which acts through 
inhibiting GTPases. Since LRG-47 is a GTPase, I am proposing that LRG-47 is a target for 
3MA. This would explain why there is no heightened Brucella killing seen when 3MA is 
used in addition to the knockout of LRG-47 in B. abortus infected cells. Also in previous 
studies involving the autophagy pathway, an autophagosome-like extracellular organelle 
which was termed a ‘bariphore’ was observed.  It was determined that the bariphore shares 
many characteristics with the autophagy pathway.  Using siRNA and dominant negative 
protein expression as well as confocal microscopy, I was able to determine that bariphores 
are released from the cell as an autolysosome before degradation of vesicular contents has 
 95  
occurred. In addition, it was observed that B. abortus is able to exploit the autophagy 
pathway to traffic intercellularly via the bariphore, and possibly using this as a persistence 
mechanism.   
It is reasonable to say that by in LRG-47-/- cells the production or appropriate vesicular 
trafficking of bariphores containing Brucella may have been inhibited.  Without the 
appropriate release of the Brucella-containing bariphores, the infection was unable to persist 
inside the host.  It isn’t necessarily that Brucella spp. require LRG-47 for their survival, but 
they require the appropriate vesicular trafficking which is regulated by LRG-47.  Moreover, 
it is possible that Brucella spp. require LRG-47 to appropriately regulate the bariphore 
trafficking and release from the host cell, allowing the Brucella population to persist.   
Recommendations for Future Research 
Now that it has been determined that LRG-47 is vital for the survival and replication of 
B. abortus in murine macrophages, it is important to determine if the same is true for other 
subtypes of Brucella. LRG-47 and other members of the p47 GTPase family are pathogen 
specific with the ability to decipher between two pathogens that share >99% of their open 
reading frames as in Chlamydia trachomatis and C. muridarum with C. trachomatis infection 
being kept at bay by LRG-47, but not C. muridarum (6). In the future it will be important to 
perform similar experiments using B. melitensis to determine the role of LRG-47 in this 
related subtype’s ability to survive and replicate inside the host. Similarly, trafficking, 
survival, and replication experiments with Ig-opsonized and non-opsonized B. melitensis in 
IFN-γ activated and non-activated cells will be important to report any differences in 
behavior of this closely related subtype. Though the mouse has proven to be a good model 
for Brucella infection, it is important to look further into the impact of LRG-47 on B.abortus 
infection in human monocytes in the future. 
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Through the previous studies involving the autophagy pathway, much information was 
collected regarding the characterization and intra- and intercellular trafficking of the 
bariphore. There is still much more research to be done to detail the mechanism of release 
and uptake of the bariphore.  Vesicle fusion events in exocytosis and endocytosis are 
controlled by membrane proteins called soluble N-ethylmaleimide-sensitive factor 
attachment protein receptors (SNAREs) of which there are several classes (7). The previous 
studies determined that bariphores are taken into a target cell by a membrane fusion event. In 
order to determine if SNAREs are involved in bariphore uptake, it would be interesting to 
treat bariphore producing cells with anti-SNARE antibodies in an attempt to inhibit the 
uptake of the bariphore into the target cell. It has been speculated that vacuolar H+-ATPase 
(V-ATPase) in the autolysosome membrane can also assist in vesicle docking and membrane 
fusion (8). This can also be tested by treating the cells with antibodies specific for V-ATPase 
to inhibit uptake of bariphores by target cells.  
In the previous studies we were able to determine that B. abortus uses bariphores to 
traffic from one host cell to another while evading the host immune system.  Recognizing 
this important mechanism of persistence for the bacterium within the host has provided a new 
opportunity to discover drug targets to inhibit chronic Brucella infection. One possible drug 
target may be the GTPase, Rab7.  In the previous studies we were able to show that Rab7 is 
required for the production and release of bariphores in RAW264.7 cells.  By infecting cells 
transfected with a dominant negative Rab7 construct and performing the supernatant transfer 
experiments as well as intracellular viability experiments explained in these studies it could 
be determined if Rab7 is important for Brucella transport in bariphores. It was also shown in 
these studies that LC3α and β are important in bariphore release. LC3α/β siRNA could be 
used to determine if LC3α and β are important in Brucella intercellular trafficking and 
infection persistence in a host.  This could also be done using knockout mice, though other 
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complications would have to be considered when inhibiting the process of autophagy in both 
cells and an animal model. Finally, it was discussed earlier the importance of LRG-47 in 
vesicular trafficking and the impact this may have had on bariphore formation and Brucella 
survival. In order to determine if LRG-47 plays any role in bariphore maturation or release it 
will be important to knockdown LRG-47 using siRNA and observe its effect on bariphore 
production and release. Secondly, these same experiments involving siRNA for LRG-47 will 
have to be repeated and the cells infected with virulent Brucella.  Supernatant transfer 
experiments will need to be performed to determine if LRG-47 is important in Brucella 
intercellular trafficking in bariphores. 
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